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ABSTRACT 
This clinical trial was based on determining, firstly, whether shockwave therapy was 
an effective form of treatment for iliotibial band syndrome and, secondly, whether 
treatment directed to the iliotibial band, tensor fascia lata and gluteus maximus 
complex was more effective than targeting the iliotibial band alone. The treatment 
protocols included: shockwave therapy delivered to the iliotibial band, tensor fascia 
lata and gluteus maximus myofascial trigger points. 
Thirty participants were recruited randomly and distributed into three groups of 10 
participants each. All participants were between the ages of 18 and 60 years and 
were chosen after meeting the inclusion criteria. Group One received shockwave 
therapy treatment to the iliotibial band myofascial trigger points. Group Two received 
shockwave therapy treatment to the tensor fascia lata and gluteus maximus 
myofascial trigger points. Group Three received shockwave therapy treatment 
directed at the iliotibial band, tensor fascia lata and gluteus maximus myofascial 
trigger points.  
A total of six treatment consultations over a period of three weeks with a seventh 
consultation where only measurements were taken was performed in this clinical trial. 
Measurements were taken on the first, fourth and seventh consultations. After the 
patient read and signed the information letter and informed consent, a full case 
history, physical examination, hip regional and knee regional examination were 
performed at the first consultation. Subjective data included the Numerical Pain 
Rating Scale. Objective data included two Pressure Algometer readings of the most 
severe trigger points along the iliotibial band, tensor fascia lata and gluteus maximus 
muscles and Goniometer readings for the hip range of motion.  
The statistical data were analysed using the Friedman test for intra-group analysis 
and the Kruskal-Wallis test was used for inter-group analysis. Results exhibited that 
all three groups decreased in iliotibial band syndrome pain and improved trigger point 
threshold with the Pressure Algometer. However, Group Two revealed the greatest 
improvement for the hip range of motion.  
Therefore, due to the improvement from the data collected above, it can be assumed 
that shockwave therapy directed to the tensor fascia lata and gluteus maximus 
muscles is imperative when treating iliotibial band syndrome and that it is necessary 
to concentrate on all three muscular structures instead of the iliotibial band alone.  
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CHAPTER ONE: INTRODUCTION 
1.1 Introduction  
Running and cycling are two of the most common forms of exercise within the human 
population. From 2008 to 2018, the number of marathon runners has risen drastically 
with a 49.43% increase in participation, with the African continent establishing an 
immense 505.74% increase alone (Andersen & Nikolova, 2019). South Africa is 
among the top three countries where five kilometre races are the most popular form 
of running (Andersen, 2019).  
Twelve percent of all overuse injuries regularly occurring in athletes, particularly 
runners, is Iliotibial band syndrome (ITBS) (Fredericson & Wolf, 2005:451–459). ITBS 
is a prevalent injury that results in pain on the lateral aspect of the knee due to 
inflammation of the distal attachment of the Iliotibial band (ITB). This inflammation 
occurs as a result of the friction of the ITB over the lateral femoral condyle during 
repetitive flexion and extension of the knee joint. Therefore, it is more likely to occur 
in runners and cyclists as they require constant and cyclical knee flexion and 
extension during training. With an increase in running amongst numerous countries 
around the world, both casually and competitively, this condition will afflict one in ten 
runners, therefore it is important to treat it efficiently.  
1.2 Aims 
Various treatment options have been shown to be effective in the treatment of this 
condition however these are aimed to target the ITB alone. The ITB is a thick 
tendinous structure which makes it difficult to stretch and therefore causes marked 
tightness compared to other muscles. This leads the structure to become tauter 
quicker during exercise and can hinder the amount of training for an athlete. There is 
evidence that the gluteus maximus muscle and the tensor fascia lata (TFL) play an 
integral part in ITBS (Falvey, Clark, Franklyn‐Miller, Bryant, Briggs & McCrory, 2010). 
It may be just as important to treat other anatomical structures that contribute to 
ITBS, such as gluteus maximus and TFL, rather than the ITB only (Falvey et al., 
2010). This research aimed to understand firstly, whether shockwave therapy is an 
effective form of treatment for ITBS and secondly, if it is essential that practitioners 
consider ITBS as a result of a complex muscle dysfunction formed by the triad, ITB, 
TFL and gluteus maximus muscle, rather than just a singular possible cause of the 
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ITB alone.  
1.3 Possible outcomes 
This research analysed the treatment of shockwave therapy to the ITB alone versus 
a combination of the gluteus maximus and TFL muscle. The outcomes from this 
clinical trial will help practitioners treat ITBS more effectively and establish better 
treatment responses with quicker return to activity following treatment. This can 
indicate to practitioners that there is a synergistic effect when treating the 
ITB/TFL/gluteus maximus muscle complex, which will allow quicker and more 
effective treatment of ITBS. 
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CHAPTER TWO: LITERATURE REVIEW 
2.1 Introduction 
This chapter will discuss the anatomy of the iliotibial band (ITB) as well as other 
structures that play an integral part in iliotibial band syndrome (ITBS) and their 
normal and abnormal biomechanical links to it. It will also examine the shockwave 
therapy machine and the reason it has been utilised for this condition, specifically for 
the treatment of myofascial trigger points (MFTPs). 
2.2 Anatomy 
2.2.1 Iliotibial band  
The ITB is a thick tendinous structure formed from the confluence of the TFL as well 
as the gluteus maximus (Figure 2.1). The ITB originates from the iliac crest via the 
TFL. It inserts on the intermuscular septum of the femur laterally just proximal to the 
lateral femoral epicondyle. Distally, the ITB will distribute out towards the patella, 
lateral retinaculum of the knee and insert on Gerdy’s tubercle of the tibia 
(Fredericson & Wolf, 2005). The function of the ITB is to decrease adduction of the 
thigh during walking and running. It also offers stability to the leg and lateral aspect of 
the knee. The ITB allows for flexion and extension of the knee due to its attachments 
and assists these movements (Fairclough, Hayashi, Toumi, Lyons, Bydder & 
Benjamin, 2006). 
2.2.2 Tensor Fascia Lata 
The TFL muscle originates from the anterior aspect of the iliac crest and anterior 
superior iliac spine and inserts into the iliotibial band (Figure 2.1) just inferior to the 
greater trochanter of the femur. It is innervated by the superior gluteal nerve (L5, S1). 
The main action is flexion, abduction and internal rotation of the hip joint. It also 
assists in keeping the pelvis level during weight-bearing (Moore, Dalley & Agur, 
2010). 
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Figure 2.1: Visual image of the gluteus maximus and TFL forming the origin of the ITB 
(Source: Falvey et al., 2010) 
2.2.3 Gluteus Maximus 
The gluteus maximus originates on the posterior aspect of the iliac crest, sacrum, 
sacrotuberous ligament and coccyx. The superficial portion of the gluteus maximus 
muscle inserts into the ITB. The other deep quarter of the muscle will attach to the 
gluteal tuberosity of the femur. This is the largest muscle in the body by weight. Its 
main action is extension and it assists in the external rotation of the hip. It also 
stabilises the thigh and assists in rising from a seated position. The innervation for 
this muscle is the inferior gluteal nerve (L5, S1, S2) (Moore et al., 2010). 
2.3 Hip joint 
The hip joint is a typical ball-and-socket joint that allows flexion, extension, adduction, 
abduction, circumduction and rotation (internal and external). The deep surface of the 
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acetabulum accommodates the head of the femur. A fibrocartilage pad extends like 
an arc on either side of the acetabular notch. The acetabular labrum projects from 
the fibrocartilage in order to increase the depth and stability of the joint. The articular 
capsule of the hip joint is very dense and robust enclosing both the head and neck of 
the femur preventing the femoral head from moving out of the acetabulum (Moore et 
al., 2010).  
Four extensive ligaments reinforce the articular capsule, three of them being 
thickenings of the capsule itself, namely, iliofemoral, pubofemoral and ischiofemoral. 
The fourth ligament is the transverse acetabular ligament which spans the acetabular 
notch. A fifth ligament, called the ligamentum teres, originates from the transverse 
ligament and inserts into the fovea capitis (small pit) on the femoral head. The 
combination of the ball and socket joint, capsule, ligaments and musculature ensures 
that the hip joint is extremely stable (Moore et al., 2010). 
2.4 Knee joint 
The knee joint is a hinge joint which transfers weight from the tibia to the femur and 
permits flexion and extension with very limited rotation. The articulating joints are 
between the femur and tibia on the medial and the lateral condyles. Another 
important articulating surface which occurs in the knee is between the patella and the 
patella surface of the femur (Moore et al., 2010). A pair of a fibrocartilage pads, 
named the medial and lateral menisci, sit between the condylar surfaces of the femur 
and the tibia. The functions are (Moore et al., 2010): 
• to operate like a cushion; 
• to adapt to the shape of the articulating surfaces as the femur alters positions; 
and 
• to offer lateral stability to the joint. 
The patella ligament, which is a continuation of the patella tendon arising from the 
patella bone, aids in extension of the knee. It also gives off medial and lateral patella 
retinacula which support the anterior surface of the knee. The posterior surface of the 
knee is reinforced by the popliteal ligaments which run from the femur to the head of 
the fibula and tibia. The anterior cruciate ligament (ACL) and posterior cruciate 
ligament (PCL), within the joint capsule, attach the intercondylar surfaces of the tibia 
and femur. They cross each other and prevent anterior and posterior displacement of 
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the tibia. The medial and lateral collateral ligaments support the medial and lateral 
surfaces of the knee and prevent medial and lateral displacement of the tibia 
respectively and are taut only during knee extension (Moore et al., 2010).  
During full knee extension, the tibia undergoes minimal lateral rotation which results 
in the ACL becoming stretched and wedges the lateral meniscus in the knee joint. 
The muscles surrounding the joint will need to contract to release the knee from the 
locked extended position which will then medially rotate the tibia, causing flexion 
(Moore et al., 2010).  
2.5 Biomechanics 
2.5.1 Lumbar spine 
There are five lumbar spine vertebrae, namely, L1 to L5 that are the largest vertebrae 
and are oval shaped. They transmit substantial loads from the L5 intervertebral disc 
(IVD) and disperse them to the sacral base, sacroiliac joints and acetabulae 
(Peterson & Bergmann, 2002). 
Weight bearing is the most important function for the lumbar spine. Forces can be 
due to body weight, a force generated from lifting objects as well as activities that 
involve forceful muscle movements. The lumbar spine is vital for trunk mobility and 
therefore numerous stresses are placed on this region (Peterson & Bergmann, 
2002).  
The facet (zygapophyseal) joints bear 18% of the vertebra’s total load but can 
contribute up to 33% of compression strength. L3 to L5 facets carry more weight than 
other areas and the posterior processes provide up to 45% of torsional strength 
within a vertebra motion unit. The IVD contributes 45% and the interspinous ligament 
provides 10%. Different postures will vary these percentages (Schafer, 1983). 
2.5.2 Pelvis 
The pelvis is the link between the axial and the lower limbs and is made up of the 
sacrum and the fused pelvic girdle, namely, the ilium, pubic and ischium bones.  
The sacrum is made up of five fused segments and is angled anterior inferiorly with 
the posterior surface convex and the anterior surface concave. The S1–S3 segments 
are wider anteriorly than posteriorly to allow articulation with the broad ilia. This 
concave sacral articulation with the congruent ilia, which limits motion and offers 
7 
 
stability, is named the sacroiliac joint (SIJ) (Peterson & Bergmann, 2002). 
2.5.3 Sacroiliac joint 
The SIJ serves as the point where the axial skeleton articulates with the pelvis 
therefore it is imperative that it remains bilaterally durable. The strength of the joint is 
dependent on the musculature and ligaments that surround and support it. The 
following ligaments assist in this (Berlemann, Jeszensky, Bühler & Harms, 1999): 
• sacroiliac ligaments (interosseous and posterior sacroiliac); 
• accessory sacroiliac ligaments (iliolumbar, sacrotuberous and sacrospinous).  
Muscle action is indirect via the ilia, ischia, hip and lumbar attachments areas. The 
muscles that have close links to the ligaments are (Berlemann et al., 1999): 
• lower fibres of the quadratus lumborum which mix with the iliolumbar ligament; 
• iliopsoas fibres that blend with the anterior sacroiliac ligament; 
• multifidi and sacrospinalis fibres that join with the posterior sacroiliac ligament; 
• fibres of the gluteus maximus as well as the hamstrings which mix with the 
sacrotuberous ligament; and 
• piriformis fibres which similarly intertwine with the sacrotuberous ligaments 
with a few fibres inserting into the sacroiliac capsule.  
A leg length discrepancy (LLD) is the phenomenon where one lower limb appears to 
be shorter than the other. It occurs in about 70% of the population thus it is vital to 
test for as it can be the reason for many injuries, including ITBS. LLD affects gait 
kinematics and kinetics such as rearfoot inversion angle and knee adduction moment 
(Resende, Kirkwood, Deluzio, Cabral & Fonseca, 2016).  
There are two types of short leg, namely, anatomical and functional. An anatomic 
short leg will result in a downward pelvic tilt and will yield a functional scoliosis with 
the convex side towards the shortened limb. However, during lying down or sitting, 
the scoliosis will disappear. A functional short leg can be due to sacroiliac joint 
dysfunction and is not a true shortening of the lower limb. A chiropractic adjustment 
may reduce the dysfunction and restore equal lower limb length. With a functional 
short leg, the foot will pronate on the longer limb as a result of the innominate 
rotating. Myofascial tightness of the muscles, mainly the TFL, along with foot 
supination and a pes cavus will be characteristic of the short leg (Berlemann et al., 
1999). 
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2.5.4 Knee joint 
The knee is considered a first-class lever where the fulcrum is at the point of weight 
bearing contact. During gait and viewing the knee anterior to posterior, the body’s 
weight is medial to the knee therefore the centre of rotation (fulcrum) is centred over 
the medial condyle (Moore et al., 2010).   
The medial and lateral collateral ligaments, fascia lata of the leg and biceps femoris 
tendon all sustain equilibrium within the knee. This is important as forces from the 
body during gait are increased three to five times more on the knee. Typically, the 
resultant joint forces are located on the medial aspect of a healthy knee. The line of 
action spreads from the distal femur through the tibia with the fibula bearing no 
weight (Peterson & Bergmann, 2002). 
During loading, the knee joint and tibia are exposed to medial compressive forces as 
well as lateral tensile forces which move the tibia laterally in relation to the femur. 
Medial ligaments of the knee will counteract this during gait (Peterson & Bergmann, 
2002). 
2.6 Myofascial Trigger Points  
Myofascial trigger points (MFTPs) are an area of extreme tenderness within skeletal 
muscle that is noticeable with a palpable nodule. It can cause autonomic, motor and 
sensory conditions which lead to myofascial pain disorders. These areas of 
hypersensitivity can cause pain when pressed as well as areas of referred pain. The 
referral pattern will distinguish MFTP from fibromyalgia (Lavelle, Lavelle & Smith, 
2007). 
A MFTP is defined as a muscular dysfunction at the level of the motor end plate as 
well as the sarcoplasmic reticula due to excessive acetylcholine release. This 
dysfunction leads to a local contraction of the sarcomere initiating an ischemia 
induced hypoxia. A local energy crisis occurs leading to a sensitisation of 
neighbouring nociceptors – resulting in pain. A neurogenic inflammation process 
ensues leading to tissue oedema. This will aggravate the energy crisis preventing the 
uptake of calcium into the sarcoplasmic reticulum which would eliminate the 
sarcomere contraction. Treatment of a MFTP is considered a success when the 
vicious local energy crisis loop ceases and normal muscle function is restored. This is 
usually achieved with therapeutic treatment involving pressure release (Travell & 
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Simons, 1993). 
MFTPs occur after a traumatic injury to the muscle or a microtrauma that occurs over 
time. Diagnostic criteria of MFTPs include a good history and a physical examination. 
On physical examination, the doctor should be able to point to the area of pain and 
feel a taut band within the muscle. Upon compression of this band, a predictable 
referral pattern may appear specific to that muscle (Lavelle et al., 2007).  
Treatment of MFTPs can lead to a decrease in pain, tenderness, an increased range 
of motion and improvement of quality of life (Shah, Thaker, Heimur, Aredo, Sikdar & 
Gerber, 2015). 
2.7 Cadaveric studies of the correlation between Gluteus Maximus 
and Tensor Fascia Lata with the Iliotibial Band 
A study aimed at identifying the anatomy of the ITB within 20 embalmed cadavers 
was performed using deep dissection (Falvey et al., 2010). The aims were to 
investigate the origin of the ITB and the relationship it has with the TFL; the insertion 
site of the gluteus maximus into the ITB; the area of the ITB attachment to the linea 
aspera; and the location of the attachment of the ITB to the lateral femoral condyle.  
The results showed that the ITB is a thickening and continuation of the fascia lata, 
and that it covers the leg completely, as seen in Figure 2.2 (b). The ITB is connected 
to the femur along the linea aspera from the greater trochanter to and including the 
lateral femoral epicondyle by stiff fibrous bands (Figure 2.2 (c)). No findings of bursae 
were reported in any of the cadavers. The TFL inserts directly into the ITB and acts 
as a lengthened tendon. Vast amounts of the gluteus maximus inserts within the ITB 
(Figure 2.2a) with the rest of the muscle inserting into the greater trochanter with the 
two portions being autonomous. This indicates that the treatment of the ITB should 
be directed to the TFL/gluteus maximus muscle complex as this plays an important 
role in tensioning of the ITB (Falvey et al., 2010). It is warranted that soft tissue 
modalities and therapy should be directed to MFTPs of muscles. 
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Figure 2.2: Posterior view of dissected specimens of ITB: (a) TFL and gluteus 
maximus shown to form ITB, which is enveloped in fascia lata; (b) ITB is thickening of 
fascia lata rather than a separate entity; (c) Intermuscular septum attaching ITB to the 
femur, dividing vastus lateralis (VL) from biceps femoris (BF) 
(Source: Falvey et al., 2010) 
2.8 Iliotibial band syndrome  
2.8.1 Definition 
Iliotibial band syndrome (ITBS) is also known as iliotibial band friction syndrome 
(ITBFS) and is a common condition where the patient presents with lateral knee pain 
near the lateral femoral condyle. The constant friction of the distal ITB over the lateral 
femoral epicondyle is the source of the pain. This will consequently be worsened with 
repetitive flexion and extension of the knee (Khaund & Flynn, 2005). As the leg is 
extended, the ITB moves anterior to the epicondyle and then posterior during flexion 
and will remain tense in both positions. The pain occurs when the posterior aspect of 
the ITB impinges on the lateral femoral condyle just after foot strike and this zone 
rises slightly less than 30⁰ knee flexion (Fredericson & Wolf, 2005). The site of friction 
of the ITB will then become a source of inflammation which will further increase the 
pain of ITBS. Magnetic resonance imaging (MRI) on patients with ITBS showed a 
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thickening of the distal ITB with the space underneath it becoming inflamed and filled 
with fluid (Khaund & Flynn, 2005). 
2.8.2 Pathology 
ITBS is the most common lateral knee injury in runners as 12% and 12.8% of all 
overuse injuries being ITBS in running and cycling respectively. The initial theory 
surrounding ITBS is that it is due to the constant friction of the lateral ITB over the 
lateral femoral epicondyle as mentioned above, however there is dispute around the 
mechanism of this injury. Fairclough et al. (2006) suggest that, since the anatomy of 
the distal ITB is firmly anchored to the lower end of the femur, this prohibits it from 
the anterior-posterior movement over the lateral femoral epicondyle and thus a 
frictional syndrome is unlikely. They explain that the repetitive series of tightening 
during exercise results in the slight medial-lateral movement of structures beneath 
the ITB, which have a recurring compression consequence that will, in turn, cause 
the pain. The main source of pain is due to the compression of a greatly vascularised 
and innervated coat of fat and loose connective tissue (Figure 2.1) that divides the 
ITB from the epicondyle. There is rarely a bursa found beneath the ITB and 
Fairclough et al. (2006) believe that this connective tissue may be mistaken for a 
bursa.  
2.8.3 Aetiology 
The following factors, which are intrinsic and extrinsic, contribute to ITBS 
(Fredericson & Wolf, 2005; Khaund & Flynn, 2005; Else, 2016; Farrel, Reisinger & 
Tillman, 2002; Falvey et al., 2010): 
Intrinsic: 
Previous ITB tightness; pes planus; pes cavus; genu varum; leg length inequality; 
knee muscular weakness; weakness/inhibition of the lateral gluteal muscles; 
increased muscular tension of ITB; weak hip abductors and over-pronation of the 
foot. 
Extrinsic: 
Interval training; downhill running; wearing old shoes when running; running and 
cycling training errors; cycling seat too high; running on a cambered road repetitively 
and an increase in weekly exercise mileage or increased time spent walking or 
running.  
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2.8.4 Patient evaluation 
2.8.4.1 History 
Patients will initially present with lateral knee pain, burning and sharp in nature, which 
is worsened with exercise, namely, running and cycling. The pain frequently starts 
several minutes into training and relieves with rest. Athletes with untreated ITBS may 
notice the symptoms start earlier during exercise and persist into rest (Fredericson & 
Wolf, 2005). 
2.8.4.2 Physical Examination 
On physical examination, the doctor will palpate tenderness over the ITB two to three 
centimetres proximal (site where the band moves over the lateral femoral condyle) to 
the lateral knee joint line. Pain may also be palpated over the lateral joint line, 
popliteal tendon, lateral collateral ligament or anterior fat pad. There may be visible 
swelling over the distal ITB. Sometimes crepitation, snapping and mild pitting 
oedema as well as paraesthesia and pain can extend the ITB (Fredericson & Wolf, 
2005). A positive Noble’s compression and Ober’s test will also indicate ITBS (Reese 
& Bandy, 2003).  
2.8.5 Treatment  
Various treatment options have proven to be effective. There should be an 
application of rest, ice and non-steroidal anti-inflammatory drugs (NSAIDs) which will 
initially decrease inflammation. Deep transverse frictional massage and cortisone 
injections can also be applied to the ITB for treatment. Therapists should also look to 
correctly alternate training and for trainers to reteach the correct running gait for 
runners. An exercise protocol for increasing hip abductor strength and stretching the 
ITB will have a positive outcome on ITBS pain. These treatment options do not 
require the patient to purchase any products and can be performed at home 
(Weckström & Söderström, 2016).  
Myofascial restrictions should be focussed on during treatment to help with physical 
therapy and soft tissue therapy is an effective treatment option for pain reduction and 
can definitively treat the condition (Fredericson & Wolf, 2005). Foam rolling treatment 
of the ITB with chiropractic manipulation to lumbar spine restrictions also reduces 
pain (Else, 2016). 
Radial shockwave therapy has been proven to be effective in treating ITBS when 
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applied to the ITB alone as evidenced by 55% of patients being pain-free after one 
session per week for four weeks. This number increased to 75% of pain-free patients 
after eight weeks of therapy all of whom remained pain-free at six months post-
treatment (Weckström & Söderström, 2016). 
Treating ITBS conservatively, as described above, has been shown to be effective. If 
ITBS persists after conservative treatment then surgical intervention is recommended 
(Figure 2.3). The procedure involves the removal of the ITB bursa (Figure 2.4) which 
sits directly beneath it. In a study where 11 patients with ITBS were surgically 
treated, all were able to return to preinjury activity levels postoperatively and the 
visual analogue scales (VAS) diminished on average by six points. This bursectomy 
intervention leads to the belief that ITBS is caused by the compression and tightening 
of the “bursa” (mistakenly, as it is usually connective tissue) underneath it (Hariri, 
Savidge, Reinold, Zachazewski & Gill, 2009:1417–1424). 
 
 
 
 
 
 
 
 
Figure 2.3: ITB incision by the lateral femoral condyle 
(Source: Hariri et al., 2009) 
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Figure 2.4: Excised ITB “bursa”  
(Source: Hariri et al., 2009) 
2.9 Shockwave therapy 
2.9.1 History 
In 1980, extracorporeal shockwave therapy (ESWT) was initially used with 
procedures in vivo primarily for the breakdown and subsequent treatment of renal 
and ureteric calculi. This was followed by a similar procedure for the use in 
gallbladder calculi in 1985 (Raveendran, 2015). 
Acoustic waves were then effectively used for the treatment of non-union long bone 
fractures in Germany in 1988. In the 1990s, shockwave therapy was, for the first 
time, used to treat plantar fasciitis, lateral epicondylitis and calcific rotator cuff 
tendinitis. Shockwave therapy is still regularly used to treat musculoskeletal disorders 
(Raveendran, 2015). 
2.9.2 Types of shockwave therapy 
2.9.2.1 Focused shockwave therapy 
Shockwave therapy is produced by electrohydraulic, electromagnetic and 
piezoelectric devices. It focuses the acoustic force on a precise location of the target 
tissue with varied focal volume, penetration depth, level of energy influx density and 
total force administered (Romeo, Lavanga, Pagani & Sansone, 2014). 
In electrohydraulic devices, firstly, a large voltage is released. Following the 
vaporisation of the water surrounding the applicator, a primary shockwave is 
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generated. An oval reflector then guides the wave to a focal area. Secondly, within 
electromagnetic devices, shockwaves are produced by a coil and converged by an 
acoustic lens onto the targeted area. Finally, a piezoelectric system has a spherical 
cap which has distorted crystals along it. This produces a series of waves which, 
organised together, will assemble on the targeted area (Romeo et al., 2014). 
For the best therapeutic results, a precise identification of the treated area is 
necessary, particularly when higher energy levels are used. Therefore, ultrasound 
and radiographic guidance is required for soft tissue conditions and patient feedback 
is sufficient.  
2.9.2.2 Radial shockwave therapy 
Radial shockwave therapy (from a shockwave therapy machine) occurs when 
compressed air hits a projectile that is enclosed within a cylinder. The applicator is 
found at the top of the cylinder and is applied to the skin via ultrasound gel. The 
pressure wave formed from the projectile produces energy when it makes contact 
with the skin’s surface via the applicator. The pressure wave then diverges and 
weakens as it penetrates deeper within the tissue to produce a therapeutic effect 
(Romeo et al., 2014). 
2.9.3 Therapeutic effects 
Delayed union or non-union of fractured bone is commonly treated with surgery. 
Extracorporeal shockwave therapy is a safe and non-invasive alternative to surgery 
that promotes bone repair via a characteristic biological response which is 
distinguished by the production of growth factors and growth morphogenetic proteins 
(BMPs). It is believed that shockwave therapy causes osteoblast proliferation which 
will, in turn, affect the upregulation of genes involved in skeletal development and 
osteoblastic lineage differentiation (Romeo et al., 2014). 
Shockwave therapy is regularly used to treat tendinopathies. Jumper’s knee (patellar 
tendinopathy) has a success rate that varies from 73.5% to 87.5%. Compared to 
conservative treatments, ultrasound examinations have shown a vast increase in the 
vascularity of the patellar tendon as well as a reduction in patellar tendon thickness 
(Wang, 2012). Achilles tendinopathy is another condition where shockwave therapy 
is effective. This condition enjoys similar success rates to patellar tendinopathy.  
Fifty participants were split in two with one group receiving eccentric stretching 
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exercises and the other group receiving ESWT. The latter was shown to be superior 
in the treatment of recurring Achilles tendinopathy (Rompe, Furia & Maffulli, 2008).  
Shockwave therapy facilitates the treatment of MFTP by causing the degeneration of 
free nerve endings and also produces a momentary dysfunction of nerve volatility by 
inducing a collapse of the acetylcholine receptor at the neuromuscular junction. 
Shockwave therapy causes the disruption of the actin-myosin links as they are 
moving perpendicularly to the sarcomere contraction (Ramon, Gleitz, Hernandez & 
Romero, 2015). 
Shockwave therapy has been shown to be as successful as progressive pressure 
release on active MFTP within the trapezius muscle. A study by Ibrahim, Amin and 
Raoof (2017) showed that there was a significant increase in the pain pressure 
threshold of trigger points one and two with 64.6% and 62.2% participant recruitment 
respectively. Shockwave therapy is therefore regarded as one of the most effective 
forms of treatment for myofascial pain syndrome (Ibrahim et al., 2017). 
2.10 Conclusion 
The research collected above substantiates the need to investigate the treatment 
options surrounding ITBS. It is believed that the muscles forming the ITB should also 
be assessed and treated when dealing with this condition as they may affect the 
lateral-medial compression of the ITB on the sensitive tissue underneath it. As a 
result, the biomechanics of the foot, knee and hip joints are affected and shockwave 
therapy is an effective form of MFTP treatment and therefore can be proven to be 
just as effective in ITBS.  
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CHAPTER 3: METHODOLOGY 
3.1 Introduction 
This chapter will explain and describe the study design, selection criteria, 
randomisation, treatment approach, ethical considerations and methods of analysis 
of this study. 
3.2 Study design 
This study was based, firstly, on determining whether treatment using shockwave 
therapy of the iliotibial band (ITB), tensor fascia lata (TFL) and gluteus maximus 
myofascial trigger points (MFTPs) can be used as an effective treatment for iliotibial 
band syndrome (ITBS) and, secondly, if a combination of treatment of all three 
muscles is a more successful form of treatment. The treatment protocols included: 
shockwave therapy to the ITB, shockwave therapy to the gluteus maximus and TFL 
MFTPs and, lastly, a combination of these. The different treatment protocols and 
their respective therapies are discussed in more detail later in this chapter.  
Participants who volunteered to participate in this research were required to visit the 
University of Johannesburg Chiropractic clinic for a consultation. Initially, they were 
required to read and sign the information letter (Appendix A), read and sign the 
research consent form (Appendix B), and sign the patient informed consent form 
(Appendix C) before any treatment began. Once that was completed within the initial 
consultation, a detailed case history (Appendix D) was performed, as well as a full 
physical examination (Appendix E), hip (Appendix F) and knee (Appendix G) regional 
examination which diagnosed the patient with ITBS. Once the correct documentation 
was completed, the first treatment session was performed which was detailed on a 
Subjective, Objective, Assessment and Plan (SOAP) note (Appendix H). The SOAP 
notes also described the subjective and objective findings, diagnosis and the 
treatment which followed.  
3.3 Selection criteria 
Thirty patients were recruited with lateral knee pain via advertisements (Appendix I) 
placed around the University of Johannesburg Doornfontein campus, within the 
Chiropractic Day Clinic, the notice boards of running and cycling clubs (with their 
permission (Appendix J)) and via word-of-mouth. In order to make University of 
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Johannesburg students eligible for recruitment, permission was obtained from Dr 
Nonkwelo (Executive Director: Research & Innovation) (Appendix K). The Higher 
Degrees Committees (Appendix L) and Research Ethics Committee clearance letter 
(Appendix M) allowed the researcher to perform this clinical trial and trial registration 
with the Pan African Clinical Trials Registry (Appendix N) was approved. 
Once participants were in contact with the researcher, a consultation followed. The 
researcher went through the paperwork mentioned above to confirm they met all the 
necessary requirements with regards to the exclusion and inclusion criteria. 
Participants were able to withdraw freely at any time from the trials without penalty. 
Thirty participants were divided into three groups with ten participants in each group. 
Participants ranged from 18 to 60 years old and included both genders. 
3.4 Inclusion criteria 
The inclusion criteria were:  
• Participants were required to present with the diagnostic criteria for ITBS 
(Noble, 1979; Khaund and Flynn 2005) (Appendix O). 
• Participants were required to be aged between 18 and 60 years old. This was 
due to an increase in degeneration of the knee joint found in patients older 
than 60 years (Arendt-Nielsen, Nie, Laursen, Laursen, Madeleine, Simonsen & 
Graven-Nielsen, 2010). 
• Participants must have had active trigger points within all three muscular 
structures on the same side as the lesion (ITB, gluteus maximus and TFL 
muscles) and meet the diagnostic criteria for MFTP (Gleitz and Hornig, 2012). 
The diagnostic criteria for a MFTP require the doctor to palpate a taut band 
within a painful area of a muscle. During compression of the taut band, the 
patient should feel a referred pain along a very predictable pattern which is 
specific to that muscle. A local twitch response should occur during 
compression of the band. There will also be a decrease in mobility of a muscle 
with an active MFTP due to shortening that takes place. Muscle weakness will 
be noticeable, but this will ensue with absent neurological deficits.  
 
a) Noble’s Compression Test 
The participant lay in a comfortable supine position on the bed. With the participant’s 
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leg flexed to 90⁰, the doctor contacts his/her thumb over the lateral aspect of the 
knee where the ITB courses over the lateral femoral epicondyle. Upon compression 
of the band, the patient was asked to extend his/her leg. If the patient experienced 
sharp severe pain at 30⁰ of flexion, then a positive Noble’s compression test was 
indicated. This aided in diagnosing ITBS (Noble, 1979). This test was completed in a 
private consulting room. 
 
b) Ober’s Test 
The patient lay on his/her side on the bed with the lesion side up and with the hip and 
knee flexed. The doctor then passively extended the patient’s affected hip and flexed 
the leg to 90⁰. The doctor released the extended lower limb. In a normal patient, the 
leg would adduct and drop towards the floor. If the patient’s leg remained abducted, 
then it is indicated that the ITB is particularly taut (preventing adduction) which was a 
sign for ITBS (Reese & Bandy, 2003). This test was completed in a private consulting 
room. 
3.5 Exclusion criteria 
The following conditions or symptoms which showed up in the history or physical 
examination would exclude participation as they are contraindicated with shockwave 
therapy (Gleitz & Hornig, 2012): 
• Participants with any malignant or neoplastic conditions. 
• Areas that need to be avoided with shockwave therapy contact: 
a. Pulmonary tissues  
b. Epiphyseal plates  
c. Large vessels  
d. Nervous tissue 
• Participants who are pregnant or may be pregnant and are unaware of it.  
• Participants who are currently on any antithrombotic therapies. 
• Participants currently receiving treatment for ITBS. 
• Whether the participant has received non-steroidal anti-inflammatory drugs 
(NSAIDS) or analgesics within the last two to four weeks. 
 
  
20 
 
3.6 Random allocation 
There were three groups of ten participants each. Participants who met the criteria 
were randomly allocated into one of the three sample groups consisting of ten 
participants each. Allocation to a group was conducted with participants drawing a 
number from a box.  The box contained 30 pieces of paper, 10 with a “1” on them, 10 
with a “2” on them and 10 with a “3” on them, which represented Group One, Group 
Two, and Group Three. The number that the participants drew determined the group 
they were in. Group One received shockwave therapy treatment to the ITB MFTP, 
Group Two received shockwave therapy treatment to the gluteus maximus and 
tensor fascia lata MFTPs, and Group Three received shockwave therapy to the ITB, 
gluteus maximus and tensor fascia lata MFTPs. Group allocation was completely 
random. This reduced bias and each treatment was considered equal and could be 
assigned to any given experimental unit.  
3.7 Treatment approach 
All treatments and measurements were performed at the University of Johannesburg 
Chiropractic Day Clinic. The treatments were performed within a secure and private 
treatment room, so the participants’ privacy was maintained.  
During the first consultation, participants were required to read the information form 
and sign the consent form provided before undergoing the trials. The researcher then 
took a thorough case history, physical examination, hip regional and knee regional. 
This was to diagnose ITBS as well as to make sure the participant did not have any 
underlying reason that would exclude them from the trials. Once the paperwork was 
completed and the diagnosis of iliotibial band syndrome was determined with the use 
of Noble’s Compression test and Ober’s test, the researcher captured the subjective 
data which included the Numerical Pain Rating Scale (NPRS) (Appendix P). 
Thereafter, the objective data were captured which included goniometer (Appendix 
Q) range of motion readings of the affected hip and Pressure Algometer (Appendix 
R) readings of the MFTPs of the ITB, tensor fascia lata and gluteus maximus. 
The participant then lay comfortably for the area that was to be treated. Members of 
group one, which was shockwave therapy of the ITB only, lay on their side, Group 
Two also lay on their side for tensor fascia lata MFTPs and then moved to a prone 
position to expose the gluteus maximus MFTPs. Members of group three lay on their 
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side during therapy of the ITB and tensor fascia lata before they moved into a prone 
position for the gluteus maximus to be treated. Once the patient was in a suitable 
position for the muscle that was to be treated, the researcher exposed the area 
effectively using towels while keeping the patient covered comfortably preventing 
unnecessary exposure.  
After the shockwave therapy machine was turned on, the correct settings were 
applied. An intensity of 2 to 4 bars (depending on the muscle), 1000 pulses and 
between 4 and 20 Hertz (Hz) (depending on the pain threshold of the patient) are 
indicated for hardened muscles due to MFTP. The researcher used the settings 
between 2 and 3 bar pressure with 1000 pulses and 12 Hz per muscle (Gleitz & 
Hornig, 2012). The bar pressure was determined by participant tolerance. The 
researcher then palpated the most active MFTP in the muscle/s that were to be 
treated. This is the site of application of the shockwave therapy machine. The 
researcher then applied suitable ultrasound gel to the skin of the region that was 
treated and contacted the transducer of the shockwave therapy applicator to the skin 
while maintaining a firm pressure. The researcher then commenced the treatment.  
Participants were treated six times bi-weekly over three weeks with a seventh 
consultation for measurements only. Measurements from the NPRS, goniometer and 
the Pressure Algometer were recorded at the first, fourth and seventh consultations. 
Measurements were taken before treatment and subjective data were captured 
before objective data. This was done to prevent altering the NPRS score after the 
use of a Pressure Algometer on the MFTPs.  
3.8 Subjective data 
3.8.1 Reliability and validity 
Reliability refers to the consistency of the measurements being taken from an 
instrument or a test. Therefore, if the conditions are the same when measurements 
are taken repeatedly, then the data that are collected should be the same. Validity 
refers to the degree of accuracy of the concept measured in trials (Heale & Twycross, 
2015). 
3.8.2 Numerical Pain Rating Scale (NPRS) 
NPRS is both a reliable and valid form of data collection of pain intensity in adults 
(Hjermstad, Fayers, Haugen, Caraceni, Hanks, Loge, Fainsinger, Aass & Kaasa, 
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2011).  The NPRS was used to depict the pain intensity in a clear and easily 
recorded way. Participants were required to fill out an NPRS form which graded the 
ITB pain from 0 to 10, with ten being the most painful and zero being no pain. This 
was then used to determine the ITB pain throughout the trials.  
Data from the NPRS was taken during the first, fourth and seventh consultations.  
3.9 Objective data 
3.9.1 Reliability and validity 
Reliability refers to the consistency of the measurements being taken from an 
instrument or a test. Therefore, if the conditions are the same when measurements 
are taken repeatedly, then the data that are collected should be the same. Validity 
refers to the degree of accuracy of the concept measured in trials (Heale & Twycross, 
2015). 
3.9.2 Goniometer 
A Goniometer was one of the two objective forms of measurement. Two readings 
were recorded at each measurement session and a mean between the two was 
calculated to determine the best value. The device was used to measure the hip 
range of motion (in degrees) to determine the difference over time due to the 
treatment applied to the ITB, gluteus maximus and TFL muscles. The test-retest 
range of motion for the hip joint is reliable, even in unskilled practitioners (Kim & Kim, 
2016). Values were recorded at the first, fourth and seventh sessions. The 
goniometer was supplied by the University of Johannesburg chiropractic clinic. 
3.9.3 Pressure Algometer 
The second form of objective data was recorded using a Pressure Algometer 
(kg/cm²). During the measurement consultations, a Pressure Algometer was applied 
to the MFTP of the muscles involved which determined the sensitivity to pressure of 
the instrument. The device tested the pain intensity of each MFTP.  
The researcher palpated over the MFTPs in each muscle and used the instrument on 
the most painful and palpable MFTP for each muscle at each consultation. The 
researcher then took two readings, 30 seconds apart, at each measurement session 
and calculated the mean reading. The use of the Pressure Algometer in MFTP is 
both reliable and valid (Reeves, Jaeger & Graff-Radford, 1986). Data from the 
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Pressure Algometer were taken at the first, fourth and seventh consultations. The 
Pressure Algometer was supplied by the University of Johannesburg chiropractic 
clinic. 
3.10 Shockwave therapy  
The Dolorcast Smart20 radial shockwave therapy machine was used in the research 
trials. The researcher used settings that were between 2 and 3 bar pressure with 
1000 pulses and 12 Hz per muscle (Gleitz & Hornig, 2012). The bar pressure was 
determined by patient tolerance. The shockwave therapy machine was supplied by 
the University of Johannesburg chiropractic clinic. 
3.11 Ethical considerations 
All participants who wished to take part in this study were requested to read and sign 
the information letter and sign the consent form specific to this research. The 
information letter and the consent form supplied the names of the researcher, the 
purpose of the study, the benefits of participating in the study, participant assessment 
and treatment procedure. Any risks, benefits and discomforts pertaining to the 
treatments involved were also explained and that the participant’s safety would be 
ensured (prevention of harm). The information and consent form also explained that 
the participant’s privacy was protected as only the doctor, patient and clinician were 
in the treatment room and that the patient’s information was converted into data and 
therefore could not be traced back to the individual. The form also stated that 
standard doctor/patient confidentiality would be adhered to when the research 
dissertation was compiled. The participants were informed that their participation was 
voluntary and that they were free to withdraw from the study at any stage without any 
consequences. After the trials, participants who required further treatment were 
availed of it. The researcher answered any further questions and gave the 
participants his contact details. The participants were then required to sign the 
consent form, signifying that they understood all that was required of them for this 
study. They were informed that results of the study would be made available on 
request.  
Participants were made aware that shockwave therapy of MFTPs is safe yet poses a 
mild risk or discomfort for them. These included: a slight increase in local pain over 
the area while the shockwave treatment was applied and a slight reddening and 
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bruising in the area following treatment. These were normal responses to shockwave 
therapy to MFTP but the researcher would cease the treatment immediately if the 
participant experienced extreme pain or wished to stop. If any pathologies were 
detected upon examination, the participants were referred to the necessary health 
care professionals.  
Dr Nonkwelo was notified of this study and allowed the researcher to treat 
participants institutionally. 
3.12 Data analysis 
The researcher collected all the data during the study period using the NPRS, 
Goniometer and Algometer. All measurements were recorded on a spreadsheet 
along with age and gender. The data were then analysed with the assistance of 
Jaclyn de Klerk from STATKON who is located at the University of Johannesburg 
Kingsway Campus. The analysis included: 
• The Shapiro-Wilk test that determined the test for normality per group; 
• The Kruskal-Wallis test that was used to determine inter-group analysis;  
• The Mann-Whitney test as a post hoc test that was used to identify where the 
difference is between the groups; 
• The Friedman test that determined intra-group analysis;   
• The Wilcoxon Signed Ranks test as a post hoc test that was used to identify 
where the difference was between the treatment sessions; and 
• The Pearson Chi-Square that tested the cross-tabulation between groups. 
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CHAPTER FOUR: RESULTS 
4.1 Introduction 
The objective of this study was twofold: firstly, whether shockwave therapy was an 
effective form of treatment for iliotibial band syndrome (ITBS) and, secondly, to 
determine whether shockwave therapy applied to a combination of the gluteus 
maximus muscle, tensor fascia lata (TFL) muscle and iliotibial band (ITB) could be 
used as an effective treatment method in patients with ITBS. 
All participants in this study were required to complete a subjective form of 
measurement via a Numerical Pain Rating Scale (NPRS) and two objective forms of 
measurements with a Pressure Algometer, which tested trigger point tenderness, and 
the Goniometer, which tested hip range of motion. Both forms of data were taken on 
the first, fourth and seventh visits before treatment commenced for that session.  
The data collected from the clinical trial of this study were analysed and interpreted 
with the supervision of STATKON, the University of Johannesburg’s preferred 
statistical consultation service. The data that were collected were statistically 
analysed in order to conclude which of the three different approaches for the 
treatment of ITBS was of more statistical significance or which group yielded the best 
results. If there were any statistical differences noted within the data, further tests 
were performed. 
The results are presented in three separate sections: 
• The Demographic Data 
o Age of participants  
o Gender of participants 
• Subjective data collection 
o Numerical Pain Rating Scale 
• Objective data collection 
o Pressure Algometer 
o Goniometer 
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4.2 Demographic data 
4.2.1 Age distribution 
The age distribution for this study is tabulated below in Table 4.1. Participants were 
required to be between the ages of 18 and 60 years. This age range eliminated the 
need for parental consent and reduced the risk of other conditions that could be the 
source of knee pain, such as osteoarthritis, which is at a lower risk in adults under 
the age of 60 (Arendt-Nielsen et al., 2010). 
Table 4.1: Age distribution 
Characteristics 
Group One 
n=10 
Group Two 
n=10 
Group Three 
n=10 
Total 
n=30 
p-value 
Mean age 24.60 32.50 30.40 29.17 0.157 
p-value 0.732 0.024 0.030 - - 
Median 25.00 28.50 26.00 25.00 - 
Standard 
Deviation 
1.43 11.12 8.34 8.49 
- 
Age (min–max) 22–27 23–55 22–44 22–55 - 
One, Shockwave Iliotibial band; Two, Shockwave TFL and Gluteus Maximus; Three, Combination 
A total of 30 participants (n=30) took part in the study.  
Group One (Shockwave ITB Group) consisted of ten participants (n=10) with the 
mean age of 24.60 (SD±1.43) and is not statistically significant with a p-value of 
0.732 (p > 0.05). The median age was 25.00 years. The youngest participant was 22 
years old while the oldest participant was 27 years old.  
Group Two (Shockwave to TFL + Gluteus Maximus Group) consisted of ten 
participants (n=10) with the mean age of 32.50 (SD±11.12) and is statistically 
significant with a p-value of 0.024 (p < 0.05). The median age was 28.50 years. The 
youngest participant was 23 years old and the oldest participant was 55 years old.  
Group Three (Combination Group) consisted of 10 participants (n=10) with the mean 
age of 30.40 (SD±8.35) and is statistically significant with a p-value of 0.030 (p < 
0.05). The median age was 26.00 years. The youngest participant was 22 years old 
and the oldest participant was 44 years old.  
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The p-value for the ages between the three groups is 0.157 (p > 0.05) and is not 
statistically significant.  
4.2.2 Gender distribution 
The gender distribution for this study is tabulated below in Table 4.2. Males and 
females were included in this study as the study was not gender specific.  
Table 4.2: Gender distribution 
Characteristics 
Group One 
n=10 
Group Two 
n=10 
Group Three 
n=10 
Total 
n=30 
Males (Percentage) 3 (30%) 4 (40%) 4 (40%) 11 (36.7%) 
Females (Percentage) 7 (70%) 6 (60%) 6 (60%) 19 (63.3%) 
Total (Percentage) 10 (100%) 10 (100%) 10 (100%) 30 (100%) 
One, Shockwave Iliotibial band; Two, Shockwave TFL and Gluteus Maximus; Three, Combination 
A total of 30 participants (n=30) were included in the study.  
Group One (Shockwave ITB Group) consisted of 10 participants (n=10). Three were 
male (30% gender distribution) and seven were female (70% gender distribution).  
Group Two (Shockwave to TFL + Gluteus Maximus Group) consisted of 10 
participants (n=10). Four were male (40% gender distribution) and six were female 
(60% gender distribution). 
Group Three (Combination Group) consisted of 10 participants (n=10). Four were 
male (40% gender distribution) and six were female (60% gender distribution). 
4.2.3 Test for normality 
The Shapiro-Wilk test was used to test for normality as the p-value determined the 
significance of the statistics from the study. The p-value stands for the probability. A 
p-value of more than or equal to 0.05 is indicative of a normal distribution. If the p-
value was less than or equal to 0.05 (p ≤ 0.05), it denoted a statistically significant 
finding that was indicative of an abnormal distribution. This meant that there was a 
difference between the groups or over time. If the p-value was greater than 0.05 
(p > 0.05), the findings were of no statistical significance as they were normally 
distributed. However, if the results of the Shapiro-Wilk test yielded an abnormal 
distribution within the sample, non-parametric tests were used to further analyse the 
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data. 
4.3 Statistical data 
A test for normality determines whether further analysis requires parametric or non-
parametric tests. Parametric tests are used to analyse the data if normality is found 
within the sample. Due to the nature of the small group sample of 30 participants 
used in this research study, non-parametric tests were used even though some 
values were normally distributed. Non-parametric tests are used to analyse the data 
if no normality is found within the sample.  The Friedman test was used for the 
comparison within the three groups (intra-group) and the Wilcoxon Signed Rank test 
was used for post hoc testing to determine the difference over time and which 
treatment sessions the difference occurred. The Kruskal-Wallis test was used for 
comparison between the three groups (inter-group) and the Mann-Whitney test was 
used for post hoc testing to determine where the difference occurred between the 
three groups. This specific post hoc test uses the Bonferroni procedure, which sets a 
significance cut off, because performing multiple independent or dependent statistical 
tests at the same time can significantly increase the probability with each test done.  
For this clinical trial, a Bonferroni adjustment was applied to the p-value for the post 
hoc tests. This involved dividing the p-value of 0.05 by the number of tests involved. 
The p-value, to be used when trying to determine the statistical significance, was now 
0.025. Therefore, a p-value of p ≤ 0.025 showed statistical significance. 
4.4 Subjective data analysis 
4.4.1 Numerical Pain Rating Scale 
The numerical pain rating scale is a scale from zero to 10. This would indicate the 
level of pain which the participant was experiencing, on the side in which they 
experienced ITBS. These subjective measurements were taken on consultations 
one, four and seven before treatment began to measure the participants’ pain levels 
throughout the course of the trial. The numerical value of zero is indicative of no pain 
and the numerical value of 10 is indicative of immense pain. A decrease in the mean 
value between visits was indicative of an improvement in the levels of pain which the 
participants were experiencing from ITBS. An increase in the mean value between 
visits was indicative of worsening in the levels of pain that the participants were 
experiencing from ITBS. 
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The Shapiro-Wilk test was conducted as the preliminary test to determine if the data 
had a normal distribution. 
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Table 4.3: Group means and Standard Deviation of visits one, four and seven 
for NPRS, differences between groups and differences within groups 
 Visit 1 
Mean 
Visit 4 
Mean 
Visit 7 
Mean 
Percentage 
change 
between  
1–7 
Differences 
within 
groups 
Statistical 
significance 
NPRS 
Group One 
n=10 
4.80 
(SD±1.989) 
2.00 
(SD±1.155) 
0.40 
(SD±0.699) 
91.67% 
Improvement 
p=0.000 Significant 
Group Two 
n=10 
6.40 
(SD±1.776) 
3.50 
(SD±1.354) 
0.90 
(SD±0.876) 
85.94% 
Improvement 
p=0.000 Significant 
Group Three 
n=10 
5.20 
(SD±1.874) 
3.10 
(SD±2.025) 
0.50 
(SD±0.707) 
90.38% 
Improvement 
p=0.000 Significant 
Difference 
between 
groups 
p=0.217 p=0.085 p=0.326    
Statistical 
Significance 
Not 
Significant 
Not 
Significant 
Not 
Significant 
   
One, Shockwave Iliotibial band; Two, Shockwave TFL and Gluteus Maximus; Three, Combination 
(0 → 10). 
In Table 4.3 above, statistical results for the NPRS are shown. The mean value for 
Group One for the NPRS was 4.80 (SD±1.989) at the first visit. The fourth visit mean 
value decreased to 2.00 (SD±1.155) and the final and seventh visit also decreased to 
0.40 (SD±0.699). Therefore, a 91.67% improvement of perceived pain was seen.  
For Group Two, the mean value at the first visit was 6.40 (SD±1.776). The fourth visit 
mean value dropped to 3.50 (SD±1.354) and the last and seventh visit saw the mean 
value decrease to 0.90 (SD±0.876). Therefore, an 85.94% improvement of perceived 
pain can be deduced. 
For Group Three, the mean value for the first visit was 5.20 (SD±1.874). The fourth 
visit resulted in a mean value decrease to 3.10 (SD±2.025) and the last and seventh 
visit mean value was 0.50 (SD±0.707). Thus, there was a 90.38% improvement of 
perceived pain. 
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Even though a decrease of perceived pain can be seen in all three groups, a 1.6 
difference between the three groups’ starting points was noted. Group One yielded 
the best results clinically with the greatest decrease in the overall levels of perceived 
pain, from the first consultation to the seventh, as a difference of 4.20 was noted.  
The Man-Whitney and Friedman test were conducted as the non-parametric test as 
the data were not normally distributed. Due to the small sample size and outlying 
parameters, there was only a slight difference noted between the three test groups 
that was not regarded as statistically significant. 
Intra-group analysis 
The Friedman and Wilcoxon signed-rank tests were used to analyse the data, which 
yielded the following results as shown in Table 4.3: 
There was a statistical significance noted over time in Group One with a p-value of 
0.00 (p < 0.05). Subsequently, there was a statistically significant difference that was 
noted over time for Group Two with a p-value of 0.00 (p < 0.05). Group Three was 
also noted to be statistically significant over time with a p-value of 0.00 (p < 0.05). 
As the above statement indicates, during the Friedman’s tests, there were statistically 
significant differences reported within the data. Thus, the Bonferroni adjustment was 
applied for the post hoc Wilcoxon signed-rank test. The new reported p-value, 
according to the Wilcoxon signed-rank test, is 0.025. Therefore, a p-value ≤ 0.025 is 
suggestive of statistical significance. The Wilcoxon signed-rank test indicates the 
comparison of the data between the different consultations, comparing consultations 
one and four and then consultations one and seven. 
Table 4.4: Post hoc Wilcoxon signed-rank test for NPRS (p-value) 
Comparisons  
between 
consultations 
Group One  
n=10 
Group Two  
n=10 
Group Three 
n=10 
Statistical 
significance 
1–4 0.007 0.004 0.005 Significant 
1–7 0.005 0.005 0.005 Significant 
One, Shockwave Iliotibial band; Two, Shockwave TFL and Gluteus Maximus; Three, Combination 
Group One analysis: 
As reported in Table 4.4 above, there was a statistically significant difference that 
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was noted between the first and fourth consultations with a p-value of 0.007 (p < 
0.025) for Group One. As for the comparison between the first and seventh 
consultations, there was a statistically significant difference that was reported with a 
p-value of 0.005 (p < 0.025) for Group One.  
Group Two analysis: 
There was a statistically significant difference that was noted between the first and 
fourth consultations with a p-value of 0.004 (p < 0.025) for Group Two. The 
comparison between the first and seventh consultations showed a statistically 
significant difference with a p-value of 0.005 (p < 0.025) for Group Two. 
Group Three analysis: 
There was a statistically significant difference that was noted between the first and 
fourth consultations with a p-value of 0.005 (p < 0.025) for Group Three. The 
comparison between the first and seventh consultations noted that there was a 
statistically significant difference with a p-value of 0.005 (p < 0.025) for Group Three. 
Inter-group analysis 
The inter-group analysis was conducted using the non-parametric Kruskal-Wallis test 
to determine if there was a difference in measurements between the groups. These 
results are reported in Table 4.3 above. 
The Kruskal-Wallis test analysed the data from the NPRS between the three groups 
for visits one, four and seven. The difference between the three groups at 
consultation one was p=0.217 (p > 0.05) and was not deemed to be statistically 
significant. The difference between the three groups at consultation four was p=0.085 
(p > 0.05) and was therefore not deemed to be statistically significant. Consequently, 
the difference between the three groups at consultation seven was p=0.326 (p > 
0.05) and thus was not deemed to be statistically significant.  
A post hoc test is required for further analysis when there are significant differences 
between the groups. Because there were three comparable groups with no 
statistically significant differences noted, a post hoc test was not needed. 
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One, Shockwave Iliotibial band; Two, Shockwave TFL and Gluteus Maximus; Three, Combination 
Figure 4.1: Plot Graph Showing the Decline of the Mean Values for the Numerical Pain 
Rating Scale 
 
Figure 4.1 above shows the decrease in the levels of perceived pain which the 
participants in all three groups experienced from ITBS. The above graph compares 
the mean values of the NPRS from consultation one (first measurements were taken) 
to consultation four (second measurements were taken) and consultation seven, 
where the final measurements were taken. All measurements were taken prior to 
treatment.  
4.5 Objective data analysis  
4.5.1 Pressure Algometer 
A Pressure Algometer was used to measure the pain threshold of active trigger 
points in the ITB, TFL and gluteus maximus muscles. An increase in Pressure 
Algometer readings between treatments was indicative of an improvement in pain 
threshold and thus a decrease in trigger point tenderness. However, a decrease in 
Pressure Algometer readings between the treatments was indicative of a decline in 
pain threshold, thus a worsening or increase of trigger point tenderness. 
The Pressure Algometer results were analysed using the Shapiro-Wilk test to 
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determine normality of the data distribution. Due to the abnormally distributed nature 
of the data, a non-parametric test was thus further conducted. The Mann-Whitney U 
(inter-group) test was performed comparing the differences between the three 
independent groups.  
The non-parametric Friedman (intra-group) test was conducted to compare each 
group independently. This test was used to detect any differences within the groups, 
comparing treatments across multiple test attempts. This test is done only if the data 
distribution is not normally distributed, as was the case with the data that were 
collected throughout this clinical trial. 
Table 4.5: Group means and Standard Deviation of visits one, four and seven 
for Pain Pressure Algometer readings: Differences between groups and 
differences within groups 
 Muscle 
Mean 
value Visit 
1 
Mean 
Value Visit 
4 
Mean 
Value Visit 
7 
Percentage 
change 
between  
1–7 
Difference 
within 
groups 
Statistical 
Significance 
Pressure Algometer (kg/cm²) 
Group One 
n=10 
ITB 2.96 
(SD±0.827) 
3.18 
(SD±0.832) 
3.77 
(SD±1.454) 
27.36% 
improvement  
p=0.007 Significant 
TFL 3.56 
(SD±0.701) 
3.10 
(SD±0.982) 
4.19 
(SD±0.705) 
17.70% 
improvement 
p=0.011 Significant 
Gluteus 
Maximus 
3.74 
(SD±0.961) 
3.89 
(SD±1.044) 
4.78 
(SD±1.104) 
27.81% 
improvement 
p=0.014 Significant 
Group Two 
n=10 
ITB 2.01 
(SD±0.572) 
2.86 
(SD±1.113) 
3.36 
(SD±1.016) 
67.16% 
improvement 
p=0.001 Significant 
TFL 3.10 
(SD±0.565) 
3.79 
(SD±1.514) 
4.62 
(SD±1.534) 
49.03% 
improvement 
p=0.000 Significant 
Gluteus 
Maximus 
3.84 
(SD±1.056) 
4.40 
(SD±1.294) 
5.15 
(SD±1.160) 
34.11% 
improvement 
p=0.000 Significant 
Group 
Three n=10 
ITB 2.71 
(SD±0.780) 
3.17 
(SD±1.02) 
3.91 
(SD±1.270) 
44.28% 
improvement 
p=0.000 Significant 
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TFL 3.68 
(SD±1.349) 
4.19 
(SD±1.636) 
4.71 
(SD±1.357) 
27.99% 
improvement 
p=0.002 Significant 
Gluteus 
Maximus 
3.77 
(SD±0.839) 
4.32 
(SD±1.196) 
5.09 
(SD±1.194) 
35.01% 
improvement 
p=0.000 Significant 
Difference 
between 
groups 
ITB p=0.506 p=0.551 p=0.474 
 
TFL p=0.344 p=0.699 p=0.832 
Gluteus 
Maximus 
p=0.965 p=0.639 p=0.869 
Statistical 
Significance 
ITB Not 
significant 
Not 
significant 
Not 
significant 
TFL Not 
significant 
Not 
significant 
Not 
significant 
Gluteus 
Maximus 
Not 
significant 
Not 
significant 
Not 
significant 
 
Group One: Shockwave to ITB 
With regards to Group One (shockwave to ITB), a mean value for the Pressure 
Algometer of the ITB upon visit one was 2.96kg/cm² (SD±0.827), which then 
increased to 3.18 kg/cm² (SD±0.832) upon visit four and further increased to 3.77 
kg/cm² (SD±1.454) upon visit seven. Therefore a 27.36% improvement in trigger 
point tenderness of the ITB was seen. 
In Group One (shockwave to ITB), a mean value for the Pressure Algometer of the 
TFL upon visit one was 3.56 kg/cm² (SD±0.701), which then decreased to 3.10 
kg/cm² (SD±0.982) upon visit four and increased to 4.19 kg/cm² (SD±0.705) upon 
visit seven. Therefore a 17.70% improvement in trigger point tenderness of the TFL 
can be deduced. 
In Group One (shockwave to ITB), a mean value for the Pressure Algometer of the 
gluteus maximus upon visit one was 3.74 kg/cm² (SD±0.961), which then increased 
to 3.89 kg/cm² (SD±1.044) upon visit four and further increased to 4.78 kg/cm² 
(SD±1.104) at visit seven. Therefore a 27.81% improvement in trigger point 
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tenderness of the gluteus maximus can be seen. 
Group Two: Shockwave TFL and gluteus maximus 
With regards to Group Two (shockwave to TFL and gluteus maximus), a mean value 
for the Pressure Algometer of the ITB upon visit one was 2.01 kg/cm² (SD±0.572), 
which then increased to 2.86 kg/cm² (SD±1.113) upon visit four and further increased 
to 3.36 kg/cm² (SD±1.016) upon visit seven. Therefore a 67.16% improvement in 
trigger point tenderness of the ITB can be deduced. 
In Group Two (shockwave to TFL and gluteus maximus), a mean value for the 
Pressure Algometer of the TFL upon visit one was 3.10 kg/cm² (SD±0.565), which 
then increased to 3.79 kg/cm² (SD±1.514) upon visit four and further increased to 
4.62 kg/cm² (SD±1.534) upon visit seven. Therefore a 49.03% improvement in trigger 
point tenderness of the TFL can be deduced. 
In Group Two (shockwave to TFL and gluteus maximus) a mean value for the 
Pressure Algometer of the gluteus maximus upon visit one was 3.84 kg/cm² 
(SD±1.056), which then increased to 4.40 kg/cm² (SD±1.294) upon visit four and 
further increased to 5.15 kg/cm² (SD±1.160) at visit seven. Therefore a 34.11% 
improvement in trigger point tenderness of the gluteus maximus can be deduced. 
Group Three: Combination 
With regards to Group Three (combination), a mean value for the Pressure 
Algometer of the ITB upon visit one was 2.01 kg/cm² (SD±0.572), which then 
increased to 3.17 kg/cm² (SD±1.02) upon visit four and further increased to 3.91 
kg/cm² (SD±1.270) upon visit seven. Therefore a 44.28% improvement in trigger 
point tenderness of the ITB can be deduced. 
In Group Three (combination), a mean value for the Pressure Algometer of the TFL 
upon visit one was 3.68 kg/cm² (SD±1.349), which then increased to 4.19 kg/cm² 
(SD±1.636) upon visit four and further increased to 4.71 kg/cm² (SD±1.357) upon 
visit seven. Therefore a 27.99% improvement in trigger point tenderness of the TFL 
can be deduced. 
In Group Three (combination), a mean value for the Pressure Algometer of the 
gluteus maximus upon visit one was 3.77 kg/cm² (SD±0.839), which then increased 
to 4.32 kg/cm² (SD±1.196) upon visit four and further increased to 5.09 kg/cm² 
(SD±1.194) at visit seven. Therefore a 35.01% improvement in trigger point 
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tenderness of the gluteus maximus can be deduced. 
Intra-group analysis 
The Friedman and Wilcoxon signed-rank tests were used to analyse the data, which 
yielded the following results as shown in Table 4.5: 
There was a statistical significance noted over time in Group One for the ITB with a 
p-value of 0.007 (p < 0.05). In Group One, there was also a statistical significance 
over time for the TFL muscle with a p-value of 0.011 (p < 0.05). Lastly, for Group 
One, the statistical significance over time for the gluteus maximus muscle was a p-
value of 0.014 (p < 0.005).   
There was a statistical significance that was noted over time for Group Two for the 
ITB with a p-value of 0.001 (p < 0.05). The statistical significance for the TFL muscle 
over time was a p-value of 0.000 (p< 0.05). For the gluteus maximus muscle, the 
statistical significance over time was a p-value of 0.000 (p < 0.05).  
Accordingly, there was a statistical significance noted over time for Group Three of 
the ITB with a p-value 0.000 (p < 0.05). The statistical significance over time for the 
TFL muscle in Group Three was a p-value of 0.002 (p < 0.05). Lastly, for the gluteus 
maximus muscle in Group Three, there was a statistical significance with a p-value of 
0.000 (p < 0.05). 
As the above statement indicates, there were statistically significant differences 
reported within the data during the Friedman tests. Thus, the Bonferroni adjustment 
was applied for the post hoc Wilcoxon signed-rank test. The new reported p-value, 
according to the Wilcoxon signed-rank test, is 0.025. Therefore, a p-value ≤ 0.025 is 
suggestive of statistical significance. The Wilcoxon signed-rank test indicates the 
comparison of the data between the different consultations, comparing consultations 
one and four and then consultations one and seven. 
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Table 4.6: Post hoc Wilcoxon signed-rank test for Pressure Algometer (p-value) 
Comparison 
between 
consultations 
Muscle 1-4 Statistical 
Significance 
1-7 Statistical 
Significance 
Group One 
n=10 
ITB 0.139 Not Significant 0.037 Not 
Significant 
TFL 0.575 Not Significant 0.022 Significant 
Gluteus 
Maximus 
0.414 Not Significant 0.014 Significant 
Group Two 
n=10 
ITB 0.074 Not Significant 0.008 Significant 
TFL 0.050 Not Significant 0.005 Significant 
Gluteus 
Maximus 
0.019 Significant 0.005 Significant 
Group Three 
n=10 
ITB 0.007 Significant 0.005 Significant 
TFL 0.202 Not Significant 0.007 Significant 
Gluteus 
Maximus 
0.036 Not Significant 0.005 Significant 
One, Shockwave ITB; Two, Shockwave TFL + Gluteus Maximus; Three, Combination 
 
Group One analysis:  
As reported in Table 4.6 above, for the ITB there was no statistically significant 
difference that was noted between the first and fourth consultations with a p-value of 
0.139 (p > 0.025) for Group One. As for the comparison between the first and 
seventh consultations, there was no statistically significant difference with a p-value 
of 0.037 (p > 0.025) for Group One. 
For the TFL muscle, there was no statistically significant difference that was noted 
between the first and fourth visits with a p-value of 0.575 (p > 0.025) for Group One. 
For the comparison between the first and seventh visits, there was a statistically 
significant difference noted with a p-value of 0.022 (p < 0.025). 
For the gluteus maximus muscle in Group One, there was no statistically significant 
difference noted with a p-value of 0.414 (p > 0.025) between visits one and four. For 
comparison between the first and seventh visits, there was a statistically significant 
difference noted with a p-value of 0.014 (p < 0.025). 
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Group Two analysis: 
For the ITB, there was no statistically significant difference that was noted between 
the first and fourth consultations with a p-value of 0.074 (p > 0.025). For the 
comparison between the first and seventh consultations, there was a statistically 
significant difference noted with a p-value of 0.008 (p < 0.025) for Group Two. 
For the TFL muscle, there was no statistically significant difference that was noted 
between the first and fourth visits with a p-value of 0.05 (p > 0.025) for Group Two. 
For the comparison between the first and seventh visits, there was a statistically 
significant difference noted with a p-value of 0.005 (p < 0.025). 
For the gluteus maximus muscle in Group Two, there was a statistically significant 
difference noted with a p-value of 0.019 (p < 0.025) between visits one and four. For 
comparison between the first and seventh visits, there was also a statistically 
significant difference noted with a p-value of 0.005 (p < 0.025). 
Group Three analysis: 
For the ITB, there was a statistically significant difference that was noted between the 
first and fourth consultations with a p-value of 0.007 (p < 0.025). As for the 
comparison between the first and seventh consultations, there was also a statistically 
significant difference noted with a p-value of 0.005 (p < 0.025) for Group Three. 
For the TFL muscle, there was no statistically significant difference that was noted 
between the first and fourth visits with a p-value of 0.202 (p > 0.025) for Group Three. 
For the comparison between the first and seventh visits, there was a statistically 
significant difference noted with a p-value of 0.007 (p < 0.025). 
For the gluteus maximus muscle in Group Three, there was no statistically significant 
difference noted with a p-value of 0.036 (p > 0.025) between visits one and four. For 
comparison between the first and seventh visits there was also a statistically 
significant difference noted with a p-value of 0.005 (p < 0.025). 
Inter-group analysis 
The inter-group analysis was conducted using the non-parametric Kruskal-Wallis test 
to determine if there was a difference in measurements between the groups. These 
results are reported in Table 4.5 above. 
The Kruskal-Wallis test analysed the results from the Pressure Algometer, between 
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all three groups for visits one, four and seven for the ITB, TFL and gluteus maximus 
muscles. The differences between the three groups at consultation one for the ITB 
was 0.506 (p > 0.05) and was not deemed to be statistically significant. The 
difference between the three groups at consultation four for the ITB was 0.551 
(p > 0.05) and was therefore not deemed to be statistically significant. Subsequently, 
the difference between the three groups at consultation seven for the ITB was 0.474 
(p > 0.05) and thus was not deemed to be statistically significant.  
The difference between the three groups at consultation one for the TFL was 0.344 
(p > 0.05) and was not deemed to be statistically significant. The difference between 
the three groups at consultation four for the TFL was 0.699 (p > 0.05) and was 
therefore not deemed to be statistically significant. Subsequently, the difference 
between the three groups at consultation seven for the TFL was 0.832 (p > 0.05) and 
thus was not deemed to be statistically significant.  
The difference between the three groups at consultation one for the gluteus maximus 
was 0.965 (p > 0.05) and was not deemed to be statistically significant. The 
difference between the three groups at consultation four for the gluteus maximus was 
0.639 (p > 0.05) and was therefore not deemed to be statistically significant. 
Subsequently, the difference between the three groups at consultation seven for the 
gluteus maximus was 0.869 (p > 0.05) and thus was not deemed to be statistically 
significant.  
No post hoc test was required for further analysis as the differences between the 
three groups for all three muscles was deemed statistically insignificant.  
4.5.2 Goniometer 
A Goniometer was used to measure the hip range of motion of the affected side. 
These measurements included flexion, extension, abduction, adduction, internal 
rotation and external rotation. The unit of measurement for the Goniometer is 
degrees (°) therefore an increase in the degrees thus indicated an increase in range 
of motion. An increase in the measurements between treatments was indicative of an 
improvement in the hip range of motion. An increase of the hip range of motion may 
indicate a decrease in iliotibial band (ITB), tensor fascia lata (TFL) and gluteus 
maximus trigger points. However, a decrease in the measurements between the 
treatments was indicative of a decrease in hip range of motion, thus a worsening or 
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increase of ITB, TFL and gluteus maximus trigger points that may have occurred 
during treatment. 
The Goniometer results were analysed using the Shapiro-Wilk test to determine 
normality of the data distribution. Due to the abnormally distributed nature of the 
data, a non-parametric test was thus further conducted. The Mann-Whitney U (inter-
group) test was performed to compare the differences between the three 
independent groups.  
The non-parametric Friedman (intra-group) test was conducted to compare each 
group independently. This test was used to detect any differences within the groups, 
comparing treatments across multiple test attempts. This test is done only if the data 
distribution is not normally distributed, as was the case with the data that were 
collected throughout this clinical trial. 
a. Flexion of the hip joint 
The Shapiro-Wilk test was conducted as the preliminary test to determine if the data 
were of a normal distribution.  
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Table 4.7: Group means and Standard Deviation of visits one, four and seven 
for Goniometer readings (flexion): Differences between groups and differences 
within groups 
 
Mean Value 
visit 1 
Mean value 
visit 4 
Mean 
Value visit 
7 
Percentage 
change 
between 1–
7 
Difference 
within 
groups 
Statistical 
Significance 
Flexion (⁰) 
Group One 
n=10 
79.65 
(SD±15.033) 
79.75 
(SD±9.133) 
85.85 
(SD±8.547) 
7.78% 
improvement 
p=0.067 
Not 
significant 
Group Two 
n=10 
81.85 
(SD±11.972) 
81.85 
(SD±10.765) 
88.15 
(SD±9.658) 
7.70% 
improvement 
p=0.045 Significant 
Group 
Three n=10 
71.00 
(SD±17.442) 
78.65 
(SD±11.093) 
79.85 
(SD11.688) 
12.46% 
improvement 
p=0.027 Significant 
Difference 
between 
groups 
p=0.403 p=0.921 p=0.282 
 
Statistical 
Significance 
Not 
significant 
Not 
significant 
Not 
significant 
One, Shockwave ITB; Two, Shockwave TFL + Gluteus Maximus; Three, Combination 
With regards to Group One (shockwave to ITB), upon visit one, a mean value of 
79.65⁰ (SD± 15.033) was noted, which increased to 79.75⁰ (SD± 9.133) upon 
consultation four and further increased to 85.85⁰ (SD±8.547) upon consultation 
seven. Thus a 7.78% improvement in hip flexion can be deduced between visits one 
and seven.  
With regards to Group Two (shockwave to TFL + gluteus maximus), upon visit one, a 
mean value of 81.85⁰ (SD± 11.972) was noted, which remained the same with a 
mean value of 81.85⁰ (SD±10.765) upon visit four and then increased to a mean 
value of 88.15⁰ (SD±9.658) upon visit seven. Thus a 7.70% increase in hip flexion 
can be deduced between consults one and seven. 
With regards to Group Three (combination), upon visit one, a mean value of 71.00⁰ 
(SD± 17.442) was noted, which increased with a mean value of 78.65⁰ (SD±11.093) 
upon visit four and then further increased to a mean value of 79.85⁰ (SD±11.688) 
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upon visit seven. Thus a 12.46% increase in hip flexion can be deduced between 
consults one and seven. Therefore, Group Three was the most clinically significant 
for flexion of the hip joint as it had the highest percentage improvement. 
Intra-group analysis 
The Friedman and Wilcoxon signed-rank tests were used to analyse the data, which 
yielded the following results as shown in Table 4.7: 
There was no statistical significance noted over time in Group One with a p-value of 
0.067 (p > 0.05). However, there was a statistical significance that was noted over 
time for Group Two and Group Three with a p-value of 0.045 (p < 0.05) and 0.027 
(p < 0.05) respectively. 
As the above statement indicates, during the Friedman tests, there were statistically 
significant differences reported within the data. Thus, the Bonferroni adjustment was 
applied for the post hoc Wilcoxon signed-rank test. The new reported p-value, 
according to the Wilcoxon signed-rank test, was 0.025. Therefore, a p-value ≤ 0.025 
is suggestive of statistical significance. The Wilcoxon signed-rank test indicated the 
comparison of the data between the different consultations, comparing consultations 
one and four and then consultations one and seven. 
Table 4.8: Post hoc Wilcoxon signed-rank test for hip flexion (p-value) 
Comparison 
between 
consultations 
Group One n=10 Group Two n=10 Group Three n=10 
1–4 - 0.838 0.059 
Statistical 
Significance 
- Not significant Not significant 
1–7 - 0.074 0.028 
Statistical 
Significance 
- Not significant Not significant 
One, Shockwave ITB; Two, Shockwave TFL + Gluteus Maximus; Three, Combination 
Group One Analysis 
Group One reported no statistically significant difference during the performance of 
the Friedman test, therefore the Wilcoxon signed-rank test was not conducted as no 
statistical significance would be identifiable. 
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Group Two Analysis 
As reported in Table 4.8 above, after the Wilcoxon signed-rank test was performed, 
there was no statistically significant difference that was noted between the first and 
fourth consultations with a p-value of 0.838 (p > 0.025). As for the comparison 
between the first and seventh consultations, there were also no statistically 
significant differences reported with a p-value of 0.074 (p > 0.025). 
Group Three Analysis 
After the Wilcoxon signed-rank test was performed, there was no statistically 
significant difference that was noted between the first and fourth consultations with a 
p-value of 0.059 (p > 0.025). As for the comparison between the first and seventh 
consultations, there was also no statistically significant differences reported with a p-
value of 0.028 (p > 0.025). 
Inter-group analysis 
The inter-group analysis was conducted using the non-parametric Kruskal-Wallis test 
to determine if there was a difference in measurements between the three groups. 
These results are reported in Table 4.7above. 
The Kruskal-Wallis test analysed the hip flexion between the three groups for visits 
one, four and seven. The difference between the groups at visit one was 0.403 (p > 
0.05) and was not deemed to be statistically significant. The difference between the 
groups at visit four was 0.921 (p > 0.05) and was therefore not deemed to be 
statistically significant. Furthermore, the difference between the groups at visit seven 
was 0.282 (p > 0.05) and thus was also deemed to not be statistically significant.  
Subsequently, there were no statistically significant differences noted between the 
groups, therefore no post hoc test was required for further analysis. 
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Visit 1 Visit 4 Visit 7
Group 1 79,65 79,75 85,85
Group 2 81,85 81,85 88,85
Group 3 71 78,65 79,85
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Figure 4.2: Plot Graph Showing the Gradual Difference in Flexion between the Three 
Groups Using the Goniometer 
The above graph compares the mean values of the Goniometer measurements from 
visit one (first measurements were taken) to visit four (second measurement were 
taken) and visit seven, where the final measurements were taken. 
Figure 4.2 above shows that, for Groups One and Two, there was very minimal and 
no change in the mean value of flexion for the hip joint between visits one and four 
respectively. However, between visits four and seven, both Group One and Two 
increased significantly. In Group Three there was a substantial increase in the mean 
value between visit one and four while thereafter between visit four and seven there 
was minimal change. The total increase for all three groups showed that flexion was 
improved across all groups.  
b) Extension of the hip joint 
The Shapiro-Wilk test was conducted as the preliminary test to determine if the data 
were of a normal distribution. 
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Table 4.9: Group means and Standard Deviation of Visits one, four and seven 
for Goniometer Readings (extension): Differences between groups and 
differences within groups 
 
Mean Value 
visit 1 
Mean value 
visit 4 
Mean 
Value visit 
7 
Percentage 
change 
between  
1–7 
Difference 
within 
groups 
Statistical 
Significance 
Extension (⁰) 
Group One 
n=10 
25.20 
(SD±7.036) 
25.25 
(SD±4.257) 
26.80 
(SD±6.006) 
6.35% 
improvement 
p=0.407 
Not 
significant 
Group Two 
n=10 
22.00 
(SD±4.45) 
20.50 
(SD±2.108) 
23.55 
(SD±3.362) 
7.05% 
improvement 
p=0.273 
Not 
significant 
Group 
Three n=10 
22.00 
(SD±5.902) 
22.35 
(SD±6.438) 
23.15 
(SD±4.928) 
5.23% 
improvement 
p=0.050 
Not 
Significant 
Difference 
between 
groups 
p=0.317 p=0.019 p=0.167 
 
Statistical 
Significance 
Not 
significant 
Significant 
Not 
significant 
One, Shockwave ITB; Two, Shockwave TFL + Gluteus Maximus; Three, Combination 
With regards to Group One (shockwave to ITB), upon visit one, a mean value of 
25.20⁰ (SD± 7.036) was noted, which increased to 25.25⁰ (SD±4.257) upon 
consultation four and further increased to 26.80⁰ (SD±6.006) upon consultation 
seven. Thus, a 6.35% improvement in hip extension can be deduced between visits 
one and seven.  
With regards to Group Two (shockwave to TFL + gluteus maximus), upon visit one, a 
mean value of 22.00⁰ (SD±4.45) was noted, which then decreased to a mean value 
of 20.50⁰ (SD±2.108) upon visit four and then increased to a mean value of 23.55⁰ 
(SD±3.362) upon visit seven. Thus a 7.05% increase in hip extension can be 
deduced between consultations one and seven. 
With regards to Group Three (combination), upon visit one, a mean value of 22.00⁰ 
(SD± 5.902) was noted, which increased with a mean value of 22.35⁰ (SD±6.438) 
upon visit four and then further increased to a mean value of 23.15⁰ (SD±4.928) upon 
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visit seven. Thus a 5.23% increase in hip extension can be deduced between 
consultations one and seven. 
Intra-group analysis 
The Friedman and Wilcoxon signed-rank test were used to analyse the data, which 
yielded the following results as shown in Table 4.9: 
There was no statistical significance noted over time in Group One with a p-value of 
0.407 (p > 0.05). Subsequently, there was no statistical significance that was noted 
over time for Group Two and Group Three with a p-value of 0.273 (p > 0.05) and 
0.050 (p ≥ 0.05) respectively. 
The above statement indicates that, during the Friedman tests, there were no 
statistically significant differences reported within the data. Thus, the Bonferroni 
adjustment was not required as there was no need for the post hoc Wilcoxon signed-
rank test.  
Inter-group analysis 
The inter-group analysis was conducted using the non-parametric Kruskal-Wallis test 
to determine if there was a difference in measurements between the two groups. 
These results are reported in Table 4.9 above. 
The Kruskal-Wallis test analysed the hip extension between the three groups for 
visits one, four and seven. The difference between the groups at visit one was 0.317 
(p > 0.05) and was not deemed to be statistically significant. The difference between 
the groups at visit four was 0.019 (p < 0.05) and was therefore deemed to be 
statistically significant. Furthermore, the difference between the groups at visit seven 
was 0.167 (p > 0.05) and thus was deemed to not be statistically significant.  
At visit four, there was a statistical difference that was noted between the groups, so 
a post hoc Mann-Whitney test was used to determine where the difference was. 
Thus, the Bonferroni adjustment was applied for the post hoc Mann-Whitney test. 
The new reported p-value, according to the Mann-Whitney test, was 0.05. Therefore, 
a p-value ≤ 0.05 is suggestive of statistical significance. The Mann-Whitney test 
indicated the comparison of the data between the different groups, comparing Group 
One vs Group Two, Group One vs Group Three and then Group Two vs Group 
Three. 
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Table 4.10: Post hoc Mann-Whitney test for hip extension (p-value) 
Comparison between groups Visit 1 Visit 4 Visit 7 
Group One vs Group Two - p=0.003 - 
Group One vs Group Three - p=0.064 - 
Group Two vs Group Three - p=0.820 - 
One, Shockwave ITB; Two, Shockwave TFL + Gluteus Maximus; Three, Combination 
Visit one analysis 
There was no statistical significance noted during the Kruskal-Wallis test between the 
groups so therefore no post hoc test was required during visit one. 
Visit four analysis 
There was a statistical significance between the groups during visit four during the 
Kruskal-Wallis test. After the post hoc Mann-Whitney test was applied, Group One vs 
Group Two gave a p-value of 0.003 (p < 0.05) which showed that there was a 
difference between Group One and Group Two and that it was statistically significant. 
Group One vs Group Three had a p-value of 0.064 (p > 0.05) which was not 
statistically significant. Group Two vs Group Three had a p-value of 0.820 (p > 0.05) 
which was not statistically significant.  
To interpret the mean values further, on visit one, Group One started with a higher 
extension range of motion than Group Two. During visit four, both groups were at 
different points, with Group One having a slight increase in the range of motion from 
visit one and Group Two decreasing in range of motion. On visit seven, Group One 
continued to increase slightly in the range of motion, while Group Two also 
increased. Therefore, although Group One started at a higher range of motion than 
Group Two at visit one and ended at a higher range of motion at visit seven, Group 
Two had a higher percentage increase in range of motion after the last visit.  
Visit seven analysis 
There was no statistical significance noted during the Kruskal-Wallis test between the 
groups so therefore no post hoc test was required during visit seven. 
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Figure 4.3 Plot Graph Showing the Gradual Difference in Extension Between the Three 
Groups Using the Goniometer 
The above graph compares the mean values of the Goniometer measurements from 
visit one (first measurements were taken) to visit four (second measurement were 
taken) and visit seven, where the final measurements were taken. 
During visit one, Group One had a higher range of motion compared to Group Two 
and Group Three which both had the same mean value. At visit four, Group One and 
Group Three slightly increased the range of motion with Group Two decreasing in the 
range of motion. At visit seven, Group One and Group Three continued increasing 
gradually while Group Two increased significantly. 
The total increase for all three groups showed that extension was improved across all 
groups.  
c. Abduction of the hip joint 
The Shapiro-Wilk test was conducted as a preliminary test to determine if the data 
were of a normal distribution.  
  
Visit 1 Visit 4 Visit 7
Group 1 25,2 25,25 26,8
Group 2 22 20,5 23,55
Group 3 22 22,35 23,15
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Table 4.11: Group means and Standard Deviation of visit one, four and seven 
for Goniometer Readings (abduction): Differences between groups and 
differences within groups 
 
Mean Value 
visit 1 
Mean value 
visit 4 
Mean 
Value visit 
7 
Percentage 
change 
between 1–
7 
Difference 
within 
groups 
Statistical 
Significance 
Abduction (⁰) 
Group One 
n=10 
32.75 
(SD±7.765) 
34.10 
(SD±6.574) 
34.00 
(SD±8.589) 
3.82% 
improvement 
p=0.301 
Not 
significant 
Group Two 
n=10 
32.00 
(SD±5.972) 
35.45 
(SD±8.780) 
36.50 
(SD±3.704) 
14.06% 
improvement 
p=0.083 
Not 
significant 
Group 
Three n=10 
36.05 
(SD±7.312) 
35.30 
(SD±4.224) 
35.45 
(SD±3.685) 
1.66% 
decline 
p=1.000 
Not 
Significant 
Difference 
between 
groups 
p=0.442 p=0.824 p=0.728 
 
Statistical 
Significance 
Not 
significant 
Not 
significant 
Not 
significant 
One, Shockwave ITB; Two, Shockwave TFL + Gluteus Maximus; Three, Combination 
With regards to Group One (shockwave to ITB), upon visit one, a mean value of 
32.75⁰ (SD± 7.765) was noted, which increased to 34.10⁰ (SD±6.574) upon visit four 
and then decreased to 34.00⁰ (SD±8.589) upon visit seven. Thus, a 3.82% 
improvement in hip abduction can be deduced between visits one and seven.  
With regards to Group Two (shockwave to TFL + gluteus maximus), upon visit one, a 
mean value of 32.00⁰ (SD±5.972) was noted, which then increased to a mean value 
of 35.45⁰ (SD±8.780) upon visit four and then further increased to a mean value of 
36.50⁰ (SD±3.704) upon visit seven. Thus, 14.06% increase in hip abduction can be 
deduced between consultations one and seven. 
With regards to Group Three (combination), upon visit one, a mean value of 36.05⁰ 
(SD± 7.312) was noted, which decreased with a mean value of 35.30⁰ (SD±4.224) 
upon visit four and then slightly increased to a mean value of 35.45⁰ (SD±3.685) 
upon visit seven. Thus, a 1.66% decrease in hip abduction can be deduced between 
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consultations one and seven. 
Intra-group analysis 
The Friedman and Wilcoxon signed-rank tests were used to analyse the data, which 
yielded the following results as shown in Table 4.11: 
There was no statistical significance noted over time in Group One with a p-value of 
0.301 (p > 0.05). Subsequently, there was no statistical significance that was noted 
over time for Group Two and Group Three with a p-value of 0.083 (p > 0.05) and 
1.000 (p > 0.05) respectively. 
The above statement indicated that, during the Friedman tests, there were no 
statistically significant differences reported within the data. Thus, the Bonferroni 
adjustment was not required as there was no need for the post hoc Wilcoxon signed-
rank test.  
Inter-group analysis 
The inter-group analysis was conducted using the non-parametric Kruskal-Wallis test 
to determine if there was a difference in measurements between the three groups. 
These results are reported in Table 4.11 above. 
The Kruskal-Wallis test analysed hip abduction between the three groups for visits 
one, four and seven. The difference between the groups at visit one was 0.442 (p > 
0.05) and was not deemed to be statistically significant. The difference between the 
groups at visit four was 0.824 (p > 0.05) and was not deemed to be statistically 
significant. Furthermore, the difference between the groups at visit seven was 0.728 
(p > 0.05) and thus was not deemed to be statistically significant.  
Subsequently, there were no statistically significant differences noted between the 
groups, therefore no post hoc test was required for further analysis. 
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Figure 4.4: Plot Graph Showing the Gradual Difference in Abduction Between the 
Three Groups Using the Goniometer 
During visit one, Group One and Two began on similar values while Group Three had 
the largest mean value. At visit four, both Group One and Two increased in abduction 
with the latter group improving considerably. At visit four, Group Three decreased in 
abduction. At visit seven, Group One decreased slightly in the range of motion with 
Group Two continuing to increase. Group Three increased slightly from visit four but 
did not increase past the mean value at visit one.  
From visits one to seven, Groups One and Two increased in abduction while Group 
Three decreased slightly in the abduction range of motion.  
The above graph compares the mean values of the Goniometer measurements from 
visit one (first measurements were taken) to visit four (second measurement were 
taken) and visit seven, where the final measurements were taken. 
d. Adduction of the hip joint 
The Shapiro-Wilk test was conducted as the preliminary test to determine if the data 
were of a normal distribution.  
  
Visit 1 Visit 4 Visit 7
Group 1 32,75 34,1 34
Group 2 32 35,45 36,5
Group 3 36,05 35,3 35,45
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Table 4.12: Group means and Standard Deviation of visits one, four and seven 
for Goniometer readings (adduction): Differences between groups and 
differences within groups 
 Mean Value 
visit 1 
Mean value 
visit 4 
Mean 
Value  
visit 7 
Percentage 
change 
between  
1–7 
Difference 
within 
groups 
Statistical 
Significance 
Adduction (⁰) 
Group One 
n=10 
24.60 
(SD±5.430) 
24.55 
(SD±6.710) 
27.10 
(SD±7.230) 
10.16% 
improvement 
p=0.497 
Not 
significant 
Group Two 
n=10 
26.55 
(SD±4.444) 
26.45 
(SD±5.403) 
29.75 
(SD±4.084) 
12.05% 
improvement 
p=0.004 Significant 
Group 
Three n=10 
26.10 
(SD±6.552) 
26.95 
(SD±4.579) 
27.65 
(SD±4.466) 
5.94% 
improvement 
p=0.670 
Not 
Significant 
Difference 
between 
groups 
p=0.596 p=0.601 p=0.381 
 
Statistical 
Significance 
Not 
significant 
Not 
significant 
Not 
significant 
One, Shockwave ITB; Two, Shockwave TFL + Gluteus Maximus; Three, Combination 
With regards to Group One (shockwave to ITB), upon visit one, a mean value of 
24.60⁰ (SD± 5.430) was noted, which slightly decreased to 24.55⁰ (SD±6.710) upon 
visit four and then increased to 27.10⁰ (SD±7.230) upon visit seven. Thus a 10.16% 
improvement in hip adduction can be deduced between visits one and seven.  
With regards to Group Two (shockwave to TFL + gluteus maximus), upon visit one, a 
mean value of 26.55⁰ (SD±4.444) was noted, which then decreased to a mean value 
of 26.45⁰ (SD±5.403) upon visit four and then increased to a mean value of 29.75⁰ 
(SD±4.084) upon visit seven. Thus a 12.05% increase in hip adduction can be 
deduced between consultations one and seven. 
With regards to Group Three (combination), upon visit one, a mean value of 26.10⁰ 
(SD± 6.552) was noted, which then increased with a mean value of 26.95⁰ 
(SD±4.579) upon visit four and then further increased to a mean value of 27.65⁰ 
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(SD±4.466) upon visit seven. Thus a 5.94% decrease in hip adduction can be 
deduced between consultations one and seven. 
Intra-group analysis 
The Friedman and Wilcoxon signed-rank tests were used to analyse the data, which 
yielded the following results as shown in Table 4.12: 
There was no statistical significance noted over time in Group One with a p-value of 
0.497 (p > 0.05). Yet, there was a statistical significance that was noted over time for 
Group Two with a p-value of 0.004 (p < 0.05). For Group Three, there was no 
statistical significance noted over time with a p-value of 0.670 (p > 0.05). 
As the above statement indicates, during the Friedman tests, there was one group 
with statistically significant differences reported within the data. The Wilcoxon signed-
rank test indicates the comparison of the data between the different consultations, 
comparing consultations one and four and then consultations one and seven. Thus, 
the Bonferroni adjustment was applied for the post hoc Wilcoxon signed-rank test. 
The new reported p-value, according to the Wilcoxon signed-rank test, was 0.025. 
Therefore, a p-value ≤ 0.025 was suggestive of statistical significance.  
Table 4.13: Post hoc Wilcoxon signed-rank test for hip adduction (p-value) 
Comparison between 
consultations 
Group One n=10 Group Two n=10 Group Three n=10 
1–4 - 0.443 - 
Statistical 
Significance 
-  Not significant - 
1–7 - 0.012 - 
Statistical 
Significance 
- Significant - 
One, Shockwave ITB; Two, Shockwave TFL + Gluteus Maximus; Three, Combination 
Group One Analysis 
Group One reported no statistically significant difference during the Friedman test, 
therefore the Wilcoxon signed-rank test was not conducted as no statistical 
significance would be identifiable. 
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Group Two Analysis 
As reported in Table 4.13 above, after the Wilcoxon signed-rank test was performed, 
there was no statistically significant difference that was noted between the first and 
fourth consultations with a p-value of 0.443 (p > 0.025). As for the comparison 
between the first and seventh consultations, there was a statistically significant 
difference reported with a p-value of 0.012 (p < 0.025). 
Group Three Analysis 
Group Three reported no statistically significant difference during the Friedman test, 
therefore the Wilcoxon signed-rank test was not conducted as no statistical 
significance would be identifiable. 
Inter-group analysis 
The inter-group analysis was conducted using the non-parametric Kruskal-Wallis test 
to determine if there was a difference in measurements between the three groups. 
These results are reported in Table 4.12 above. 
The Kruskal-Wallis test analysed hip adduction between the three groups for visits 
one, four and seven. The difference between the groups at visit one was 0.596 (p > 
0.05) and was not deemed to be statistically significant. The difference between the 
groups at visit four was 0.601 (p > 0.05) and was not deemed to be statistically 
significant. Furthermore, the difference between the groups at visit seven was 0.381 
(p > 0.05) and thus was not deemed to be statistically significant.  
Subsequently, there were no statistically significant differences noted between the 
groups, therefore no post hoc test was required for further analysis. 
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Visit 1 Visit 4 Visit 7
Group 1 24,6 24,55 27,1
Group 2 26,55 26,45 29,75
Group 3 26,1 26,95 27,65
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Figure 4.5: Plot Graph Showing the Gradual Difference in Adduction Between the Three Groups Using 
the Goniometer 
At visit one, Group One started as the lowest adduction mean value compared to 
Groups Two and Three. However, at visit four, Group One and Group Two both 
decreased slightly in the range of motion while Group Three increased in mean alue. 
At visit seven, while Group Three maintained the increase from visits one to four and 
again from visits four to seven, Group One and Two significantly increased in the 
range of motion with Group Two ending as the principal range of motion mean value.  
The total increase for all three groups showed that adduction was improved across 
all groups.  
The above graph compares the mean values of the Goniometer measurements from 
visit one (first measurements were taken) to visit four (second measurement were 
taken) and visit seven, where the final measurements were taken. 
e. Internal rotation of the hip joint 
The Shapiro-Wilk test was conducted as the preliminary test to determine if the data 
were of a normal distribution.  
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Table 4.14: Group means and Standard Deviation of visits one, four and seven 
for Goniometer readings (internal rotation): Differences between groups and 
differences within groups 
 
Mean Value 
visit 1 
Mean value 
visit 4 
Mean 
Value  
visit 7 
Percentage 
change 
between  
1–7 
Difference 
within 
groups 
Statistical 
Significance 
Internal Rotation (⁰) 
Group One 
n=10 
26.70 
(SD±7.036) 
27.00 
(SD±5.864) 
25.30 
(SD±4.283) 
5.24% 
decline 
p=0.518 
Not 
significant 
Group Two 
n=10 
25.85 
(SD±6.000) 
26.05 
(SD±6.357) 
28.90 
(SD±5.211) 
11.80% 
improvement 
p=0.255 
Not 
significant 
Group 
Three n=10 
29.10 
(SD±12.272) 
26.65 
(SD±6.737) 
24.30 
(SD±5.509) 
16.49% 
decline 
p=0.614 
Not 
significant 
Difference 
between 
groups 
p=0.890 p=0.886 p=0.147 
 
Statistical 
Significance 
Not 
significant 
Not 
significant 
Not 
significant 
One, Shockwave ITB; Two, Shockwave TFL + Gluteus Maximus; Three, Combination 
With regards to Group One (shockwave to ITB) upon visit one, a mean value of 
26.70⁰ (SD± 7.036) was noted, which increased to 27.00⁰ (SD±5.864) upon visit four 
and then decreased to 25.30⁰ (SD±4.283) upon visit seven. Therefore, a 5.24% 
decrease in hip internal rotation can be deduced between visits one and seven.  
With regards to Group Two (shockwave to TFL + gluteus maximus), upon visit one, a 
mean value of 25.85⁰ (SD±6.000) was noted, which then increased to a mean value 
of 26.05⁰ (SD±6.357) upon visit four and then further increased to a mean value of 
28.90⁰ (SD±5.211) upon visit seven. Thus, an 11.80% increase in hip internal rotation 
can be deduced between consultations one and seven. 
With regards to Group Three (combination), upon visit one, a mean value of 29.10⁰ 
(SD±12.272) was noted, which then decreased with a mean value of 26.65⁰ 
(SD±6.737) upon visit four and then further decreased to a mean value of 24.30⁰ 
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(SD±5.509) upon visit seven. Thus a 16.49% decrease in hip internal rotation can be 
deduced between consultations one and seven. 
Intra-group analysis 
The Friedman and Wilcoxon signed-rank tests were used to analyse the data, which 
yielded the following results as shown in Table 4.14: 
There was no statistical significance noted over time in Group One with a p-value of 
0.518 (p > 0.05). There was also no statistical significance that was noted over time 
for Group Two with a p-value of 0.255 (p > 0.05) and, for Group Three, there was 
also no statistical significance noted over time with a p-value of 0.614 (p > 0.05). 
The above statement indicates that, during the Friedman tests, there were no 
statistically significant differences reported within the data over time. Thus, the 
Bonferroni adjustment was not required as there was no need for the post hoc 
Wilcoxon signed-rank test.  
Inter-group analysis 
The inter-group analysis was conducted using the non-parametric Kruskal-Wallis test 
to determine if there was a difference in measurements between the three groups. 
These results are reported in Table 4.14 above. 
The Kruskal-Wallis test analysed hip internal rotation between the three groups for 
visits one, four and seven. The difference between the groups at visit one was 0.890 
(p > 0.05) and was not deemed to be statistically significant. The difference between 
the groups at visit four was 0.886 (p > 0.05) and was not deemed to be statistically 
significant. Furthermore, the difference between the groups at visit seven was 0.147 
(p > 0.05) and thus was deemed not to be statistically significant.  
Subsequently, there were no statistically significant differences noted between the 
groups, therefore no post hoc test was required for further analysis. 
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Figure 4.6: Plot Graph Showing the Gradual Difference in Internal Rotation Between 
the Three Groups Using the Goniometer 
Group Three began as the highest mean value at visit one with Group Two being the 
lowest. Following this, at visit four, Group Three decreased significantly and both 
Group Two and One increased slightly. At visit seven, Group Three continued to 
decrease and showed a constant decline over time while Group One also decreased 
in mean value at visit seven. Group Two however increased significantly at the last 
consultation resulting in the highest mean value for internal rotation range of motion. 
The total increase for Group Two shows that internal rotation was improved only in 
this group.  
The above graph compares the mean values of the Goniometer measurements from 
visit one (first measurements were taken) to visit four (second measurements were 
taken) and visit seven, where the final measurements were taken. 
f. External Rotation of the hip joint 
The Shapiro-Wilk test was conducted as the preliminary test to determine if the data 
were of a normal distribution.  
  
Visit 1 Visit 4 Visit 7
Group 1 26,7 27 25,3
Group 2 25,85 26,05 28,9
Group 3 29,1 26,65 24,3
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Table 4.15: Group means and Standard Deviation of visits one, four and seven 
for Goniometer readings (external rotation): Differences between groups and 
differences within groups 
 
Mean Value 
visit 1 
Mean value 
visit 4 
Mean 
Value  
visit 7 
Percentage 
change 
between  
1–7 
Difference 
within 
groups 
Statistical 
Significance 
External Rotation (⁰) 
Group One 
n=10 
24.15 
(SD±6.151) 
23.10 
(SD±5.748) 
23.40 
(SD±3.332) 
3.11% 
decline 
p=0.926 
Not 
significant 
Group Two 
n=10 
29.45 
(SD±7.515) 
27.65 
(SD±5.186) 
29.60 
(SD±6.105) 
0.51% 
improvement 
p=0.172 
Not 
significant 
Group 
Three n=10 
24.00 
(SD±8.492) 
25.60 
(SD±7.249) 
26.20 
(SD±6.015) 
9.17% 
improvement 
p=0.717 
Not 
significant 
Difference 
between 
groups 
p=0.127 p=0.242 p=0.075 
 
Statistical 
Significance 
Not 
significant 
Not 
significant 
Not 
significant 
One, Shockwave ITB; Two, Shockwave TFL + Gluteus Maximus; Three, Combination 
With regards to Group One (shockwave to ITB), upon visit one, a mean value of 
24.15⁰ (SD± 6.151) was noted, which decreased to 23.10⁰ (SD±5.748) upon visit four 
and then increased to 23.40⁰ (SD±3.332) upon visit seven. Therefore, a 3.11% 
decrease in hip external rotation can be deduced between visits one and seven.  
With regards to Group Two (shockwave to TFL + gluteus maximus), upon visit one, a 
mean value of 29.45⁰ (SD±7.515) was noted, which then decreased to a mean value 
of 27.65⁰ (SD±5.186) upon visit four and then increased to a mean value of 29.60⁰ 
(SD±6.105) upon visit seven. Thus a 0.51% increase in hip external rotation can be 
deduced between consultations one and seven. 
With regards to Group Three (combination), upon visit one, a mean value of 24.00⁰ 
(SD±8.492) was noted, which then increased to a mean value of 25.60⁰ (SD±7.249) 
upon visit four and then further increased to a mean value of 26.20⁰ (SD±6.015) upon 
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visit seven. Thus a 9.17% increase in hip external rotation can be deduced between 
consultations one and seven. 
Intra-group analysis 
The Friedman and Wilcoxon signed-rank tests were used to analyse the data, which 
yielded the following results as shown in Table 4.15: 
There was no statistical significance noted over time in Group One with a p-value of 
0.926 (p > 0.05). There was also no statistical significance that was noted over time 
for Group Two with a p-value of 0.172 (p > 0.05) and, for Group Three, there was no 
statistical significance noted over time with a p-value of 0.717 (p > 0.05). 
The above statement indicates that, during the Friedman tests, there were no 
statistically significant differences reported within the data over time. Thus, the 
Bonferroni adjustment was not required as there was no need for the post hoc 
Wilcoxon signed-rank test.  
Inter-group analysis 
The inter-group analysis was conducted using the non-parametric Kruskal-Wallis test 
to determine if there was a difference in measurements between the three groups. 
These results are reported in Table 4.15 above. 
The Kruskal-Wallis test analysed hip external rotation between the three groups for 
visits one, four and seven. The difference between the groups at visit one was 0.127 
(p > 0.05) and was not deemed to be statistically significant. The difference between 
the groups at visit four was 0.242 (p > 0.05) and was not deemed to be statistically 
significant. Furthermore, the difference between the groups at visit seven was 0.075 
(p > 0.05) and thus was deemed not to be statistically significant.  
Subsequently, there were no statistically significant differences noted between the 
groups, therefore no post hoc test was required for further analysis. 
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Figure 4.7: Plot Graph Showing the Gradual Difference in External Rotation Between 
the Three Groups Using the Goniometer 
The above graph compares the mean values of the Goniometer measurements from 
visit one (first measurements were taken) to visit four (second measurement were 
taken) and visit seven, where the final measurements were taken. 
Group One and Group Three started as the lowest mean values at visit one with 
Group Two at a considerably higher starting point. At visit four, Group One and 
Group Two decreased in mean value while Group Three increased. At visit seven, all 
three groups increased after visit four with Group Two having the largest range of 
motion mean value.  
The total increase for Group Two shows that external rotation was improved only in 
Group Two and Group Three with Group One decreasing slightly between visits one 
and seven.  
4.6 Conclusion 
All three treatment protocols had a positive effect on the participants clinically and 
statistically. From a subjective perspective, all participants from all three groups had 
a decrease in their overall perceived pain, as the results from the NPRS indicated. 
Equally, the results from the Pressure Algometer yielded significant results across all 
three groups, as an improvement in trigger point tenderness was noted in the iliotibial 
band, tensor fascia lata and the gluteus maximus. However, objectively, Group Two 
Visit 1 Visit 4 Visit 7
Group 1 24,15 23,1 23,4
Group 2 29,45 27,65 29,6
Group 3 24 25,6 26,2
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performed better clinically for range of motion (ROM) overall. The results will be 
discussed in further detail in Chapter Five. 
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CHAPTER FIVE: DISCUSSION 
5.1 Introduction 
Chapter Five discusses and interprets the results from Chapter Four aided by 
literature surrounding shockwave therapy treatment, myofascial trigger points 
(MFTPs), multiple muscle complexes and the implications they have in a range of 
motion and biomechanics. This chapter also determines the clinical implications of 
this research study through finalising the effectiveness of shockwave therapy on the 
iliotibial band (ITB), tensor fascia lata (TFL) and gluteus maximus muscles. 
5.2 Demographic data 
5.2.1 Age 
Out of the total sample size of 30 participants who took part in this clinical trial, the 
minimum age was 22 years and the maximum age was 55 years. The average age 
was 29.17 years. Therefore, participants fell within the criterion for the age bracket 
(18–60 years). This eliminated the need for parental consent and reduced the risk of 
other conditions that could be the source of knee pain, such as osteoarthritis, which 
is a lower risk in adults under the age of 60 (Arendt-Nielsen et al., 2010). The 
difference between the mean ages between the three groups was not statistically 
significant 0.157 (p > 0.05). Therefore, the inter-group analysis of subjective and 
objective data was not affected by the age distribution between the three groups and 
within the groups which was comparable. 
As discussed in Chapter Two, a risk factor for iliotibial band syndrome (ITB) is 
sporting activity particularly for runners and cyclists (Fredericson & Wolf, 2005). 
Therefore, the age group that was used in this study was associated with physical 
activity and most of the injuries that had occurred were as a result of increased 
running and cycling training usually over the past few months.  
5.2.2 Gender 
Within the total sample size of 30 participants, there were 11 (36.7%) males and 19 
(63.3%) females. Therefore, the gender sample size did not affect the subjective and 
objective data between the three groups and within the three groups. Consequently, 
the data are comparable. 
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5.3 Subjective data 
The subjective data were captured using the Numerical Pain Rating Scale (NPRS) 
5.3.1 Numerical Pain Rating Scale 
Clinical Interpretation 
The NPRS was consistently used as a tool to measure and assess self-stated pain 
intensity. It is a subjective method of measuring a participant’s perceived level of pain 
to determine the increases and decreases of pain throughout a clinical trial. A 
decrease in NPRS is considered a decrease in perceived pain.  
Table 4.3 yielded clinically positive results. This means that throughout the study 
there was an overall decrease in perceived pain from ITBS for all participants in all 
three groups that received treatment. Therefore, all three groups’ treatment methods 
are considered clinically significant as a decrease in overall perceived pain 
throughout the treatment sessions was observed.  
Inter-group analysis 
Data analysis was performed to compare the results between the three groups (see 
Table 4.3). The Kruskal-Wallis test was conducted to analyse the data from the 
NPRS between the three groups for consultations one, four and seven.  
The difference noted between the three groups at consultation one was not deemed 
to be statistically significant. The difference between the three groups at consultation 
two was not deemed to be statistically significant and the difference between the 
three groups at consultation seven was also not deemed to be statistically significant. 
This indicates that the three groups were comparable at each point throughout the 
clinical trial as no group yielded better results. This shows that the treatments that 
included shockwave therapy to the ITB alone, TFL and gluteus maximus or a 
combination of both were equally effective in decreasing the NPRS scores.  
These results, as mentioned above, verify that, clinically, there was an improvement 
in pain interpretation of the participants between visits one and four, and visits one 
and seven. This indicates that there was an overall improvement clinically throughout 
all the treatment sessions for all three groups. However, Group One showed the best 
clinical improvement. This could be due to the therapeutic effects of shockwave 
therapy on the active trigger points of the ITB, TFL and gluteus maximus in ITBS.  
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Intra-group analysis 
The data were analysed using the Friedman and Wilcoxon signed-rank tests (see 
Table 4.3 and Table 4.4). This compares the data within the three groups.  
The analysis of all three groups between visits one and seven showed a 91.67% 
increase in NPRS values for Group One, with an 85.94% increase in NPRS values 
for Group Two and a 90.38% increase in NPRS for Group Three. For Group One, the 
change was regarded as statistically significant indicating that shockwave therapy to 
the ITB is effective in decreasing the participant’s perceived pain over time. For 
Group Two, the change was regarded as statistically significant indicating that 
shockwave therapy to the TFL and gluteus maximus is effective in decreasing the 
participant’s perceived pain over time. Finally, for Group Three the change was as 
regarded statistically significant indicating that a combination of shockwave therapy 
to the ITB and the TFL and gluteus maximus is statistically significant. Therefore, all 
three treatment methods were successful in decreasing the participant’s perceived 
pain and are regarded as clinically significant. 
Table 5.1: Clinical improvements with regards to NPRS readings for all three 
groups 
 
Decrease 
or increase 
% change 
Group One 
Decreased 
by 4.20 
91.67% improvement 
Group Two 
Decreased 
by 5.50 
85.94% improvement 
Group Three 
Decreased 
by 4.70 
90.38% improvement 
*a decrease in NPRS reading indicates an improvement  
 Discussion 
Accordingly, the results mentioned above, show that there was a substantial 
decrease in overall perceived pain for all three groups. Group One produced the best 
percentage change clinically as compared to Group Two and was only slightly better 
than Group Three. While Group Two had the biggest change between visits one and 
seven, it was also the group which began with the highest mean value and ended 
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with the lowest mean value score.  
Chapter Two revealed that shockwave therapy influences pain reduction in patients 
with myofascial trigger points (MFTPs). This occurs as a result of the degeneration of 
free nerve endings in the MFTPs and produces a momentary dysfunction of nerve 
volatility by inducing a collapse of acetylcholine receptors at the neuromuscular 
junction of the affected muscle. Actin-myosin links would also be disrupted as they 
move perpendicular to the sarcomere contraction (Ramon et al., 2015). 
Myofascial restrictions should be assessed and treated as an effective option 
regarding ITBS (Fredericson & Wolf, 2005). Considering that the ITB is an 
arrangement of a hardened extension of the TFL, with the insertion of a significant 
portion of the gluteus maximus muscle, it is proposed that soft tissue therapy should 
be directed to the MFTPs of the TFL and gluteus maximus along with the ITB in ITBS 
(Falvey et al., 2010). Myofascial restrictions in the ITB, TFL and gluteus maximus 
were assessed for MFTPs and treated appropriately with the shockwave therapy 
machine resulting in lowered NPRS scores which further strengthens the claim that 
treatment to the ITB/TFL and gluteus maximus complex is acceptable in ITBS. 
A study performed by Weckström and Söderström (2016) showed that 55% of 
participants who were diagnosed with ITBS were pain free after one session per 
week over four weeks. That increased to 75% of pain-free patients after eight weeks 
of therapy. Finally, 64% of participants were pain free six months after treatment. 
Therapy included a radial shockwave therapy machine applied to the affected ITB. 
Settings that were used in the trial consisted of an initial 500 shocks at 15 Hertz (Hz) 
at 2 Bar to the lateral femoral condyle. This was done to adjust to treatment. An 
additional 2000 shocks were applied at 2–4 Bar with 15 Hz depending on the 
patient’s pain tolerance. This was followed by shockwave therapy to three trigger 
points in the lateral thigh with 700 shocks at 2–4 Bar and 15 Hz. 
Similarly, shockwave therapy has been shown to be successful on active MFTP 
within the trapezius muscle. A study by Ibrahim et al. (2017) outlines that there is a 
significant increase in pain pressure threshold of trigger points one and two in 64.6% 
and 62.2% respectively of participants recruited. Shockwave therapy has been 
shown to be one of the most effective forms of treatment when it comes to myofascial 
pain syndrome (Ibrahim et al., 2017). This is supported by the pain reduction 
perceived by participants in this study over six treatment sessions and four weeks. 
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5.4 Objective data 
The objective data were collected using the Pressure Algometer to measure trigger 
point tenderness of the ITB, TFL and gluteus maximus muscles and the Goniometer 
to measure hip range of motion. 
5.4.1 Pressure Algometer 
Clinical interpretation 
In this study, the Pressure Algometer was used to measure the participants’ pain 
pressure threshold on visits one, four and seven. An increased reading between 
treatments shows an improvement of pain threshold and thus a decrease in trigger 
point tenderness. However, a decrease in Pressure Algometer readings between 
treatments suggests a decline in pain threshold and thus implies a worsening of 
trigger point tenderness.  
As there are three muscles that were assessed and treated amongst the groups, 
each muscle will be individually analysed and then all three muscles will be 
discussed collectively. 
a. ITB 
Inter-group analysis 
Data analysis was performed to compare the results between the three groups (see 
Table 4.5). The Kruskal-Wallis test was used to analyse the data from the Pressure 
Algometer readings of the ITB between all three groups for visits one, four and 
seven.  
The results prove that, clinically, there was an improvement in pain pressure 
threshold of the ITB of the participants between visits one and four, and visits one 
and seven. This indicates that there was an overall improvement clinically throughout 
all the treatment sessions for all three groups for the ITB however Group Two 
displayed the highest percentage change over the course of the trial. This could be 
due to the therapeutic effects of shockwave therapy on the active trigger points of the 
ITB, TFL and gluteus maximus.  
Intra-group analysis 
The data were analysed using the Friedman and Wilcoxon signed-rank tests (as a 
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post hoc test) (see Table 4.5 and Table 4.6) to compares the data within the three 
groups.  
All three groups had an increase in pain pressure threshold for the ITB between visits 
one and seven. All treatment methods are considered clinically significant for ITB 
MFTPs due to the increase in Pressure Algometer readings across the board.  
Table 5.2: Clinical improvements with regards to Pressure Algometer readings 
of the ITB for all three groups 
 Increase or Decrease % change 
Group One 0.81 kg/cm² increase 27.36% improvement 
Group Two 1.35 kg/cm² increase 67.16% improvement 
Group Three 1.20 kg/cm² increase 44.28% improvement 
*an increase in the Pressure Algometer reading indicates an improvement  
b. TFL 
Inter-group analysis 
Data analysis was performed to compare the results between the three groups (see 
Table 4.5). The Kruskal-Wallis test was used to analyse the data from the Pressure 
Algometer readings of the TFL between all three groups for visits one, four and 
seven.  
The results prove that, clinically, there was an improvement in the pain threshold of 
the TFL muscle of the participants between visits one and four, and visits one and 
seven. This indicates that there was an overall improvement throughout all the 
treatment sessions for all three groups for the TFL however Group Two displayed the 
highest percentage change over the course of the trial. This could be due to the 
therapeutic effects of shockwave therapy on the active trigger points of the ITB, TFL 
and gluteus maximus.  
Intra-group analysis 
The data were analysed using the Friedman and Wilcoxon signed-rank tests (as a 
post hoc test) (see Table 4.5 and Table 4.6). This compares the data within the three 
groups respectively.  
All three groups had an increase in pain pressure threshold for the TFL between 
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visits one and seven. All treatment methods are therefore considered clinically 
significant for TFL MFTPs due to the increase in Pressure Algometer readings. 
Table 5.3: Clinical improvements with regards to Pressure Algometer readings 
of the TFL for all three groups 
 Increase or Decrease % change 
Group One 0.63kg/cm² increase 17.70% improvement 
Group Two 1.52 kg/cm² increase 49.03% improvement 
Group Three 1.03 kg/cm² increase 27.99% improvement 
*an increase in the Pressure Algometer reading indicates an improvement  
c. Gluteus Maximus 
Inter-group analysis 
Data analysis was performed to compare the results between the three groups (see 
Table 4.5). The Kruskal-Wallis test was used to analyse the data from the Pressure 
Algometer readings for the gluteus maximus between all three groups for visits one, 
four and seven.  
The results prove that, clinically, there was an improvement in pain threshold of the 
gluteus maximus muscle of the participants between visits one and four, and visits 
one and seven. This indicates that there was an overall improvement throughout all 
the treatment sessions for all three groups for the gluteus maximus however, Group 
Three improved the best clinically with the highest percentage change over the 
course of the trial. This could be due to the therapeutic effects of shockwave therapy 
on the active trigger points of the ITB, TFL and gluteus maximus.  
Intra-group analysis 
The data were analysed using the Friedman and Wilcoxon signed-rank tests (as a 
post hoc test) (see Table 4.5 and Table 4.6). This compares the data between the 
three groups.  
All three groups had an increase regarding pain pressure threshold for the gluteus 
maximus between visits one and seven. All three groups’ treatment methods were 
considered clinically significant for gluteus maximus MFTPs due to the increase in 
Pressure Algometer readings.  
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Table 5.4: Clinical improvements with regards to Pressure Algometer readings 
of the gluteus maximus for all three groups 
 Increase or Decrease % change 
Group One 1.03kg/cm² increase 27.81% improvement 
Group Two 1.31kg/cm² increase 34.11% improvement 
Group Three 1.32kg/cm² increase 35.01% improvement 
*an increase in the Pressure Algometer reading indicates an improvement  
Discussion 
The results show that there was an increase in overall pain threshold over time for all 
three groups for the ITB, TFL and gluteus maximus muscles which indicates a 
decrease in total trigger point tenderness. This suggests an improvement throughout 
the clinical trial. Overall, Group Two produced the best results clinically compared to 
Group One and only slightly better than Group Three as indicated by the increased 
percentage change for all three muscles. Consistently, the lowest scores for the 
Pressure Algometer for each muscle were seen in Group One.  
An increase in pain pressure threshold from the Pressure Algometer showed an 
improvement throughout the clinical trials. This was due to the MFTPs being broken 
down from the effects of the shockwave therapy impulses that propagate 
perpendicularly to the sarcomere contractions and the Actin-Myosin links that arise in 
the taut band (Ramon et al., 2015). Taut bands of the MFTPs were reduced and the 
tenderness surrounding the MFTP of the three muscles diminished. When the 
Pressure Algometer was applied, it decreased tenderness over the MFTPs.  
The effect of shockwave therapy on MFTP has not been fully established however 
the mechanism of action is thought to separate fixed actin-myosin links with the input 
of mechanical energy perpendicular to the muscle fibre direction (as mentioned 
above).  Improved blood circulation via reactive hyperaemia and angioneogenesis is 
a result of shockwave therapy and reactive hyperaemia will also dilute 
vasoneuroactive substances. Substances P and CGRP are released, resulting in 
pain reduction, C-fibre degeneration, stimulation of biological mechanotransduction 
and pain inhibition through the pain gate control theory (Gleitz & Hornig, 2012). This 
theory states that a “gate-like” mechanism appears in the dorsal horn of the spinal 
cord where nerve impulses from peripheral receptors (pain fibres) and large (touch) 
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fibres enter the cord. Opening or closing the gate is related to the activity of the 
nerves that synapse on the dorsal horn. Pain fibres open the gate whereas 
stimulation of the touch/mechanoreceptors will close the gate. Closing of the gate 
produces pain relief therefore stimulation of mechanoreceptors, such as using a 
shockwave therapy machine, will result in a reduction of pain (Pereira & Lerner, 
2017). Shockwave therapy may have had any of these therapeutic effects on the 
MFTP of the ITB, TFL and gluteus maximus. Further studies are required to 
determine the exact cause of this.  
In Chapter Two, it was discussed that, during deep dissection of 20 cadavers, it was 
found that the ITB is a continuation of the TFL with immense amounts of the gluteus 
maximus inserting into the ITB too. Falvey et al. (2010) believe that it is warranted to 
direct soft tissue modalities towards the TFL and gluteus maximus muscles when 
treating the ITB as the tensioning of these two muscles adversely affects the ITB. 
This supports the results that found an improvement of the ITB pain pressure 
threshold in Group Two, which did not receive shockwave therapy to the ITB directly 
but to the TFL/gluteus maximus complex instead.  
Shockwave therapy has been shown to be successful on active MFTP within the 
trapezius muscle. A study by Ibrahim et al. (2017) outlined that there was significant 
increase in pain pressure threshold of trigger points one and two with 64.6% and 
62.2% respectively of participants recruited. Shockwave therapy has been shown to 
be one of the most effective forms of treatment for myofascial pain syndrome 
(Ibrahim et al., 2017). This is supported by the pain pressure threshold reduction 
perceived by participants in this study over six treatment sessions and four weeks. 
All three groups improved with regards to all three muscles which indicates the 
clinical significance of shockwave therapy on MFTPs. However, Group One that only 
received shockwave therapy to the ITB showed the least improvement over time for 
the ITB itself. This may be due to the lateral-medial application of the Pressure 
Algometer against the ITB that will adversely affect the readings. Although an 
improvement was identified, it was lower than the other two groups and this supports 
the fact that ITBS is a result of the tensioning of the ITB that leads to compression of 
the structures (namely, highly vascularised and innervated fat and connective tissue) 
and that the application of the Pressure Algometer may theoretically elicit ITBS 
(Fairclough et al., 2006). 
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5.4.2 Goniometer 
In this study, the manual Goniometer was used to measure the participants’ hip 
range of motion on visits one, four and seven. An increased reading between 
treatments shows an increase range of motion and thus diminished muscle tightness. 
However, a decreased Goniometer reading between treatments is a suggestion of a 
decline in the range of motion and thus implies a deterioration of muscle tightness. 
There are six ranges of motion that were assessed and measured amongst the three 
groups. Each range of motion will be individually analysed and all six range of 
motions will be discussed collectively. 
a) Flexion 
Inter-group analysis  
Data analysis was performed to compare the results between the three groups (see 
Table 4.7). The Shapiro-Wilk test was conducted to analyse the data from the 
Goniometer readings between all three groups for visits one, four and seven.  
The results prove that, clinically, there was an improvement in hip flexion of the 
participants between visits one and seven in all three groups. However, Group Three 
showed the best improvement. This may be due to the indirect therapeutic effects of 
shockwave therapy on the active trigger points of the ITB, TFL and gluteus maximus 
for hip flexion.  
Intra-group analysis 
Table 5.5: Clinical improvements with regards to Goniometer readings for hip 
flexion for all three groups 
 Increase or Decrease % change 
Group One 6.20⁰ increase 7.78% improvement 
Group Two 6.30⁰ increase 7.70% improvement 
Group Three 8.85⁰ increase 12.46% improvement 
*an increase in the goniometer reading is indicative of an increase in range of motion 
All three groups improved over time and are considered clinically significant. 
However, Group Three showed the best improvement and was the most effective 
treatment method for increasing flexion of the hip.  
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b) Extension 
Inter-group analysis  
Data analysis was performed to compare the results between the two groups (see 
Table 4.9). The Shapiro-Wilk test was conducted to analyse the data from the 
Goniometer readings between all three groups for visits one, four and seven.  
The results prove that, clinically, there was an improvement in hip extension of the 
participants between visits one and seven for all three groups. However, at visit four, 
Group One had a slight improvement while Group Two decreased in extension. This 
shows that Group One at visit four yielded better results. However, at visit seven, no 
clinical significance was noted and all groups ended the trial comparably. This may 
be due to the indirect therapeutic effects of shockwave therapy on the active trigger 
points of the ITB, TFL and gluteus maximus for extension.  
Intra-group analysis 
Table 5.6: Clinical improvements with regards to Goniometer readings for hip 
extension for all three groups 
 Increase or Decrease % change 
Group One 1.60⁰ increase 6.35% improvement 
Group Two 1.55⁰ increase 6.58% improvement 
Group Three 1.15⁰ increase 5.23% improvement 
*an increase in the goniometer reading is indicative of an increase in range of motion 
All three groups’ treatment methods were effective in increasing the extension of the 
hip joint.  Yet, all groups reported no statistically significant differences over time 
during the Friedman test and, from the results mentioned above, there was a general 
increase for all three groups. It can be concluded that there was a slight increase in 
overall hip extension for all three groups. However, shockwave therapy to the TFL 
and gluteus maximus had the best improvement in hip extension but all three groups 
had similar percentages so it can be assumed that all three methods influenced 
extension of the hip joint. 
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c) Abduction 
Inter-group analysis  
Data analysis was performed to compare the results between the two groups (see 
Table 4.11). The Shapiro-Wilk test was conducted to analyse the data from the 
Goniometer readings between all three groups for visits one, four and seven.  
The results prove that, clinically, there was an improvement in hip abduction of the 
participants between visits one and seven for Groups One and Two. Group Three 
had a mild decline in hip abduction. This may have been due to the indirect 
therapeutic effects of shockwave therapy on the active trigger points of the ITB, TFL 
and gluteus maximus for hip abduction.  
Intra-group analysis 
Table 5.7: Clinical improvements with regards to Goniometer readings for hip 
abduction for all three groups 
 Increase or Decrease % change 
Group One 1.25⁰ increase 3.82% improvement 
Group Two 4.50⁰ increase 14.06% improvement 
Group Three 0.60⁰ decrease 1.66% decline 
*an increase in the goniometer reading is indicative of an increase in range of motion 
Consequently, it can be concluded that there was a slight increase in overall hip 
abduction with regards to Group One. Clinically, Group Two yielded the largest 
abduction range of motion at the seventh visit. Group Two also had the highest 
percentage change between visits one and seven by a significant amount. Group 
Three started with the highest mean value for abduction however it failed to improve 
and decreased by the seventh visit. Therefore, shockwave therapy to the TFL and 
gluteus maximus had the best improvement with hip abduction which means that 
Group Two was found to have a clinical significance. 
d) Adduction 
Inter-group analysis  
Data analysis was performed to compare the results between the three groups (see 
Table 4.12). The Shapiro-Wilk test was conducted to analyse the data from the 
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Goniometer readings between all three groups for visits one, four and seven.  
The results prove that, clinically, there was an improvement in hip adduction of the 
participants between visits one and seven for all three groups. This may be due to 
the indirect therapeutic effects of shockwave therapy on the active trigger points of 
the ITB, TFL and gluteus maximus for hip adduction.  
Intra-group analysis 
Table 5.8: Clinical improvements with regards to Goniometer readings for hip 
adduction for all three groups 
 Increase or Decrease % change 
Group One 2.50⁰ increase 10.16% improvement 
Group Two 3.20⁰ increase 12.05% improvement 
Group Three 1.55⁰ increase 5.94% improvement 
*an increase in the goniometer reading is indicative of an increase in range of motion.  
Consequently, from the results above, it can be concluded that there was an increase 
in overall hip adduction for all three groups. Clinically, Group Two yielded the largest 
adduction range of motion at the seventh visit with a 3.20⁰ increase. Group Two also 
had the best percentage change between visits one and seven by a significant 
amount. Therefore, shockwave therapy to the TFL and gluteus maximus had the best 
improvement with hip adduction and is clinically significant. 
e) Internal Rotation 
Inter-group analysis  
Data analysis was performed to compare the results between the three groups (see 
Table 4.14). The Shapiro-Wilk test was conducted to analyse the data from the 
Goniometer readings between all three groups for visits one, four and seven.  
The results prove that, clinically, there was an improvement in hip internal rotation of 
the participants between visits one and seven for Group Two. This may be due to the 
indirect therapeutic effects of shockwave therapy on the active trigger points of the 
TFL and gluteus maximus for hip internal rotation.  
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Intra-group analysis 
Table 5.9: Clinical improvements with regards to Goniometer readings for hip 
internal rotation for all three groups 
 Increase or Decrease % change 
Group One 1.40⁰ decrease 5.24% decline 
Group Two 3.05⁰ increase 11.80% improvement 
Group Three 4.80⁰ decrease 16.49% decline 
*an increase in the goniometer reading is indicative of an increase in range of motion 
From the results, it can be concluded that there was a decline in hip internal rotation 
for Group One and Group Three. Clinically, Group Two yielded the largest and only 
improved internal rotation range of motion at the seventh visit with an increase of 
3.05⁰. Group Two also had the best percentage change between visits one and 
seven by a significant amount. Only Group Two showed a clinically significant 
increase while Groups One and Three showed a deterioration and were deemed to 
be clinically insignificant. Therefore, shockwave therapy to the TFL and gluteus 
maximus had the best improvement with hip internal rotation.  
f) External Rotation 
Inter-group analysis  
Data analysis was performed to compare the results between the three groups (see 
Table 4.15). The Shapiro-Wilk test was conducted to analyse the data from the 
Goniometer readings between all three groups for visits one, four and seven.  
The results prove that, clinically, there was an improvement in hip external rotation of 
the participants between visits one and seven for Group Two and Group Three. This 
may be due to the indirect therapeutic effects of shockwave therapy on the active 
trigger points of the TFL and gluteus maximus for hip external rotation.  
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Intra-group analysis 
Table 5.10: Clinical improvements with regards to Goniometer readings for hip 
external rotation for all three groups 
 Increase or Decrease % change 
Group One 0.75⁰ decrease 3.11% decline 
Group Two 0.15⁰ increase 0.51% improvement 
Group Three 2.20⁰ increase 9.17% improvement 
*an increase in the goniometer reading is indicative of an increase in range of motion 
The results show that there was an overall increase in hip external rotation for Group 
Three, a minor, unconvincing growth in Group Two and a decrease in hip external 
rotation of Group One. Group Three had the best percentage change by a substantial 
amount and had an increase between visits one and seven. Therefore, shockwave 
therapy applied to the ITB, TFL and gluteus maximus had the best improvement with 
hip external rotation. 
Discussion 
The hip joint undergoes six active ranges of motions. A normal flexion range of 
motion for the hip joint is 80⁰–90⁰ (straight knee) and 110⁰–120⁰ (bent knee) while 
extension is between 10⁰ and 15⁰. Abduction is between 30⁰ and 50⁰ and adduction is 
around 30⁰. Internal rotation is between 30⁰ and 40⁰ while external rotation has 40⁰ to 
60⁰ of movement (Vizniak, 2018). 
For this clinical trial, MFTPs of the ITB, TFL and gluteus maximus were treated with 
shockwave therapy to determine whether it was an effective form of improving the hip 
joint range of motion in patients with ITBS. ITBS is a lateral knee affliction, mainly in 
runners and cyclists that forms due to multiple extrinsic and intrinsic factors. A 
diminished range of motion may indirectly produce a functional leg length inequality 
and other biomechanical complications in the lower limbs. These may all transition 
over time to form ITBS (Resende et al., 2016; Berlemann et al., 1999). 
Overall, all three groups generally increased apart from a few outliers which led to a 
decrease over time. The standout group was Group Two. Shockwave therapy to the 
TFL and gluteus maximus was effective in increasing all ranges of motions in the hip 
joint. Four out of the six ranges of motions saw Group Two with the highest 
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improvement. Group Two had no deterioration over time in any of the groups and can 
be considered the most clinically significant treatment method regarding improving 
hip joint range of motion. Group One showed the next best improvement however 
there was a decline found over time for internal and external rotation. Group Three 
was the worst group when it came to improving hip joint range of motion and 
worsened in internal rotation and abduction between visits one and seven.  
Shah et al. (2015) believe that trigger points within muscle initiate muscle pain, 
stiffness and dysfunction which, in turn, restricts the range of motion of the affected 
joint. Gerber, Sikdar, Armstrong, Diao, Heimur, Kopecky, Turo, Otto, Gebreab and 
Shah (2013) found a decrease in the active range of motion of the cervical spine in 
participants with myofascial pain syndrome (MPS) due to MFTPs in the trapezius 
muscle compared to participants experiencing MPS without MFTPs. 
Stecco, Stern, Porzionato, Macchi, Masiero, Stecco and De Caro (2011) focused on 
the three anatomical layers: the deep fascia, the layer of loose connective tissue 
(which stores hyaluronic acid) and the epimysium layer when discussing MFTPs. 
Hyaluronic acid (HA), a main constituent of an extra cellular matrix, is found 
commonly throughout many tissues. Its acts as a lubricant which helps muscle fibres 
glide over each other with ease and without friction. However, due to traumatic injury 
or overuse, these layers begin producing large amounts of HA that aggregate to form 
supermolecular structures therefore altering viscosity. Thus, an increased viscosity of 
HA prevents it from being an effective lubricant causing resistance from muscle fibres 
abnormally sliding with one another. These will limit the range of motion.  
The results are contradictory with some ranges of motion improving and others 
worsening. A study showed that there is an improvement of the range of motion due 
to shockwave therapy in patients with knee osteoarthritis. However, this study 
included a combination of shockwave therapy and exercises (Shenouda, 2013). The 
researcher proposes that a multifactorial approach to treatment of the MFTPs could 
be more effective than attempting to increase a range of motion with the shockwave 
therapy machine alone.  
A clinical trial involving shockwave therapy of trapezius MPS found an increase in 
neck range of motion that was comparable to the results found with Transcutaneous 
Nerve Stimulation (TENS) treatment to the same area. The study included two 
groups of 15 participants each presenting with MPS in the upper trapezius muscle. 
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One group of 15 was exposed to treatment with the use of TENS combined with an 
injection into the trigger point once a week and the second group of fifteen was 
subjected to treatment using extracorporeal shock wave lithotripsy (ESWL) once 
every three weeks. Although there was an increase, it was considered an 
insignificant difference in neck ROM at the end of the study (Jeon et al., 2012). This 
further supports the theory that shockwave therapy does not have the clinical effect 
on a range of motion that we had hoped to validate with this clinical trial.  
Overall Discussion 
The NPRS and Pressure Algometer results for all three groups determined that all 
groups showed a clinically and statistically significant improvement that was noted 
throughout the treatment sessions for perceived pain and trigger point tenderness 
reduction respectively. However, Group One showed the best results for perceived 
pain percentage improvement. Group Two was clinically the best for Pressure 
Algometer readings overall for all three muscles. 
ITBS is affected by different intrinsic and extrinsic factors. Intrinsic factors, such as 
leg length inequality, foot over-pronation, pes cavus, pes planus, weakness of lateral 
gluteal muscles and increased muscular tension, all produce complications along the 
biomechanical and kinematic chains and may initiate ITBS. Falvey et al. (2010) 
believe, after deep dissection of the 20 embalmed cadavers, that soft tissue 
modalities should be directed to the MFTPs of the ITB/TFL/gluteus maximus muscle 
complex as it plays an important part in tensioning the ITB. This is shown by the 
improvement of perceived pain and trigger point tenderness from treatment of the 
ITB, TFL and gluteus maximus MFTPs 
Regarding ROM, Group Two had the best statistical and clinical significance over 
time indicating shockwave therapy to the TFL and gluteus maximus MFTPs is the 
most effective in increasing hip joint range of motion compared to shockwave therapy 
of the ITB alone or the combination of all three muscles.  
Group Three was expected to outperform the other two groups for the subjective and 
objective data as it targeted all three muscle structures that shaped the 
ITB/TFL/gluteus maximus muscle complex in this clinical trial. Although improvement 
was demonstrated for the NPRS and Pressure Algometer, ROM left unimpressive 
results. This suggests that shockwave therapy applied to the MFTPs of all three 
muscles has no benefit in increasing ROM. 
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This is evidenced by a study that was done which reviewed the effectiveness of 
shockwave therapy for myofascial pain syndrome (MFPS), focusing on MFTPs and 
fibromyalgia. The study involved two groups of 15 participants each presenting with 
MFPS in the upper trapezius muscle. Group One had 15 participants which were 
subjected to Transcutaneous Nerve Stimulation (TENS) treatment combined with an 
injection into the trigger point once a week. Group Two of another 15 participants 
was exposed to treatment using extracorporeal shock wave lithotripsy (ESWL) once 
every three weeks. No significant difference in neck ROM was noted at the end of the 
study (Jeon et al., 2012). This further suggests that shockwave therapy does not 
have the clinical effect on the range of motion that we had hoped to substantiate in 
this clinical trial.  
Group Two managed to improve amongst all six ranges of motion for the hip joint. 
This is indicative that shockwave therapy to the MFTPs may increase ROM. The 
difference between Groups Two and Three was the absence of treatment of the ITB 
in Group Two. This may be the difference that was noted between the three groups 
and further research will be required to understand why the results presented in this 
manner.    
Overall, it is difficult to determine which treatment option is the most effective since 
each group proved to be the best in various forms of data collection. All three 
treatment methods are a potential form of ITBS treatment if the goal is to reduce 
perceived pain and improve MFTP tenderness. However, taking into consideration all 
forms of data capturing, group two performed the best clinically with improvement of 
perceived pain, improvement of trigger point tenderness and increasing hip ROM. 
Group two is the best form of treatment out of the three groups in this clinical trial.  
The aim of this research was to determine whether to include the TFL and gluteus 
maximus muscles as well when treating ITBS. The improvement of perceived pain, 
pain pressure threshold and ROM in Group Two, where the ITB itself was not 
treated, suggests that it is warranted for practitioners to focus on the TFL and gluteus 
maximus (structures that form the ITB) as much as the ITB itself. It is proposed that 
the treatment of the TFL and gluteus maximus MFTPs by breaking down the taut, 
palpable bands via the shockwave therapy machine will alleviate pain and reduce 
tension in the ITB thus improving symptoms of ITBS.   
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CHAPTER SIX: CONCLUSION 
6.1 Introduction 
This chapter will discuss the results from the clinical trial described in Chapter Five in 
order to reach a conclusion. Recommendations will be suggested for related studies 
that can be done in the future in order to further this clinical trial, recommendations 
will offer improvements for this study and limitations which were found on this study 
will also be discussed. 
6.2 Conclusion 
The aim of this study was to explore the treatment of iliotibial band syndrome (ITBS) 
with shockwave therapy of the iliotibial band (ITB)/tensor fascia lata (TFL)/gluteus 
maximus muscle complex. The data from the three groups were analysed to verify 
which soft tissue approach was the most effective when treating the myofascial 
trigger points (MFTPs) of the ITB, TFL and gluteus maximus in patients presenting 
with ITBS. The expectation was for a more efficient treatment approach of ITBS 
which would allow the practitioner to treat this difficult condition much faster. 
Throughout the trial, all treatment groups generated positive clinical results for the 
subjective data that were collected using the Numerical Pain Rating Scale (NPRS). 
All three groups achieved a decrease in the participants’ perceived pain of ITBS over 
the six treatment sessions. The objective data were collected using the Pressure 
Algometer which measured pain pressure threshold and the manual Goniometer 
which measured the hip range of motion. Taking the objective data into 
consideration, the data that were collected from the Pressure Algometer readings for 
ITB, TFL and gluteus maximus all increased verifying that all three groups delivered 
a clinically positive result. Shockwave therapy resulted in an increase in the 
participants’ pain threshold for ITB, TFL and gluteus maximus, which is indicative of 
an overall decrease in pain of the trigger points in the three structures over the six 
treatment sessions. The general decrease in pain from the trigger points, as 
indicated by a decrease in NPRS and pain pressure threshold of the participants, 
suggests that, although all three treatment protocols had positive effects on the 
participants over the six consultations, none of the treatment protocols had definitive 
statistical improvements compared to the others in the treatment of ITBS. 
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The Goniometer readings of the hip range of motion were unconvincing and did not 
produce any clinical results for any of the three groups. For hip flexion, Group Three 
had the best improvement compared to the other groups however, for extension, it 
had the least improvement, a range of motion where Groups One and Two had 
similar success. For abduction, Group Two had the best improvement with Group 
Three decreasing. Group Two also had the best improvement when it came to 
adduction with Groups One and Three improving as well but not as much. For 
internal rotation, Groups One and Three suffered a decline with the latter being by a 
large margin. Group Two enjoyed an overall increase. Finally, for external rotation, 
Group Three increased while Group Two minimally increased and Group One 
decreased. We conclude that shockwave therapy to the TFL and gluteus maximus 
(Group Two) had the best range of motion improvement and was the most effective 
treatment method for improving the hip range of motion.  
Thus, the conclusion is that all three treatment protocols are effective in reducing 
pain of ITBS and any practitioner would be able to treat it effectively in these ways. 
However, if the goal is to improve the range of motion of the hip joint, shockwave 
therapy to the ITB, TFL and gluteus maximus should not be the main treatment 
focus. It is imperative that practitioners consider the ITB/TFL/gluteus maximus 
muscle complex when treating ITBS as it is shown in the results above that there is 
symptomatic improvement of ITBS. Any of the treatment methods could be utilised in 
a rehabilitation protocol for the treatment of ITBS to prevent this condition from 
worsening and to yield pain free exercise.  
6.3 Limitations 
Numerous aspects added to the limitations that were experienced during this clinical 
trial to obtain the most accurate results possible. The manual Goniometer, although 
considered reliable and valid for measuring the hip range of motion, if the same 
practitioner was using the measuring device, proved that it is difficult to produce 
comparable measurements when trying to obtain the mean value of three different 
readings taken straight after each other. 
The correct setting in which the shockwave machine was applied was undetermined, 
as the patient’s tolerance established the settings. There have been multiple studies 
on the effects of shockwave therapy however no consistency protocol exists for the 
treatment of musculoskeletal conditions. The variables differ for each study recorded, 
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which includes the number of shocks, device used, intensity (Bar), the amount of 
Hertz (Hz), type of wave (radial or focal), days between sessions, number of 
treatments, area of application and use of analgesia for the period of application. 
Therefore, as shockwave therapy has proved to have a dose-dependent effect, the 
use of different intensities and shocks may have influenced the treatment results. 
Other factors that limited the accuracy of the results are variables that could have 
played a role but cannot be controlled. These variables include limitation of 
participant’s exercise activity or sporting hobbies outside the trial which could have 
added to the participant’s ITBS and the formation of active trigger points in other 
surrounding muscles. 
6.4 Recommendations 
The recommendations below could aid in future research pertaining to the use of 
shockwave therapy for ITBS or for the treatment of ITB/TFL and gluteus maximus 
MFTPs: 
• The inclusion of additional follow up consultations at two weeks, one month 
and six months post treatment intervals to determine the long-term effects for 
each protocol. This could determine which treatment protocol has longer 
lasting clinical effects on a hip range of motion and ITBS. 
• A clinical study can be done using shockwave therapy at different intensity and 
shocks to determine which setting has a better clinical effect on treating ITBS. 
• A comparative study can be done which includes the addition of post stretch 
protocols or proprioceptive exercises along with the application of shockwave 
therapy to the MFTPs of the ITB/TFL/gluteus maximus complex. 
• A comparative study comparing other soft tissue modalities to shockwave 
therapy i.e., dry needling, TENS, IFC, sports massage or ultrasound.   
• A comparative study could be done to compare the effects of flossing of the 
hip or knee joint and the effects on a range of motion and pain reduction, to 
determine the best rehabilitation protocol for ITBS.  
• Future studies could be conducted on specific population groups, for example, 
gender, to compare the differences in pain thresholds and speed of healing, or 
a specific sporting group, in order to collect information of rehabilitation 
protocols for ITBS on a broader spectrum. 
• The range of motions that are measured could be limited to the actions which 
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are produced by the ITBS, TFL and gluteus maximus, i.e., hip flexion, 
adduction, internal rotation and extension only, instead of all motions of the hip 
joint.  
• Subjective data capturing could include a Knee Outcome Survey which is a 
Sports Activity Scale which would help with ITBS as it is an exercise related 
injury at the knee.  
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Appendix A: Information Letter 
 
 
 
 
 
DEPARTMENT OF CHIROPRACTIC 
RESEARCH STUDY INFORMATION LETTER 
(Date) 
Good day 
My name is Alastair Lunn. I would like to invite you to participate in a research study on the effect of 
shockwave therapy to the tensor fascia lata and gluteus maximus myofascial trigger points in 
patients with iliotibial band syndrome (ITBS).  
Before you decide on whether to participate, I would like to explain to you why the research is being 
done and what it will involve for you. I will go through the information letter with you and answer 
any questions you have. This should take about 10 to 20 minutes. The study is part of a research 
project being completed as a requirement for Master’s Degree in Chiropractic through the University 
of Johannesburg.   
THE PURPOSE OF THIS STUDY is to determine whether treatment applied to the tensor fascia lata 
and gluteus maximus myofascial trigger points have an effect on iliotibial band syndrome.  
Below, I have compiled a set of questions and answers that I believe will assist you in understanding 
the relevant details of participation in this research study. Please read through these. If you have any 
further questions, I will be happy to answer them for you. 
1. DO I HAVE TO TAKE PART? No, you don’t have to. It is up to you to decide to participate in 
the study. I will describe the study and go through this information sheet. If you agree to take 
part, I will then ask you to sign a consent form. 
2. WHAT EXACTLY WILL I BE EXPECTED TO DO IF I AGREE TO PARTICIPATE? You will just be 
required to come bi-weekly for six treatment sessions of shockwave therapy as well as a 
seventh measurement-only visit.  
3. WHAT IF NEW INFORMATION BECOMES AVAILABLE? Sometimes new information may 
become available about the treatment you will be receiving. If this is the case, I will tell you 
about this and discuss it with you. You can then decide whether you would like to continue 
participating in the research. If you decide not to continue, there will be no other 
consequences for you. If you do decide to continue, I will ask you to sign an updated consent 
form.  
4. APPROXIMATELY HOW LONG WILL MY PARTICIPATION TAKE? Your participation will take 
four weeks, with two consultations a week for three weeks for approximately 1 hour each. A 
measurement only session will be completed the week following the sixth treatment. 
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5. WHAT WILL HAPPEN IF I WANT TO WITHDRAW FROM THE STUDY? If you decide to 
participate, you are free to withdraw your consent at any time without giving a reason and 
without any consequences. If you wish to withdraw your consent, you should inform me as 
soon as possible.  
6. ARE THERE ANY OTHER POSSIBLE REASONS WHY MY PARTICIPATION MIGHT BE STOPPED? 
It may happen that, due to your health or other treatments that you may receive or for 
safety reasons, I will need to stop your participation in this research. I will discuss this with 
you beforehand if it becomes necessary. 
7. IF I CHOOSE TO PARTICIPATE, WILL THERE BE ANY EXPENSES FOR ME, OR PAYMENT DUE 
TO ME? You will not be paid to participate in this study, and you will not bear any expenses. 
8. IF I CHOOSE TO PARTICIPATE, WHAT ARE THE RISKS INVOLVED? There are no anticipated 
risks apart from a slight increase in local pain for a few days, reddening and bruising.  
9. IF I CHOOSE TO PARTICIPATE, WHAT ARE THE BENEFITS INVOLVED? There may be no direct 
benefit to you.  
10. HOW CAN I BE INCLUDED IN THIS TRIAL? You need to be between the age of 18-60; have 
pain on the outside aspect of your knee and have positive diagnostic testing for ITBS (which I 
will perform).  
11. WHAT WOULD EXCLUDE ME FROM THIS TRIAL? If you have received any treatment for ITBS 
within the last two weeks, you don’t fit the criteria for diagnosing ITBS or if you have any of 
the contra-indications for shockwave therapy, you cannot partake in this study. 
12.  WILL MY PARTICIPATION IN THIS STUDY BE KEPT CONFIDENTIAL? All reasonable efforts will 
be made to keep your personal information confidential and respect your right to privacy. 
This includes replacing your identifying personal information with a number that only I and 
my research supervisor will know. You will not be identified in any research reports that are 
published. Under some circumstances, such as when required to do so by a court of law, I 
may have to disclose your personal information. In addition, it may happen that your 
information will need to be reviewed by another organisation for quality assurance purposes. 
I will tell you about this if it happens.  
13. WHAT WILL HAPPEN TO THE RESULTS OF THE RESEARCH STUDY? The results will be written 
into a research report that will be assessed. In some cases, results may also be published in a 
scientific journal. In either case, you will not be identifiable in any documents, reports or 
publications. You will be given access to the results of this if you would like to see them, by 
contacting me. If you decide to seek effective treatment post-trial, you will be offered the 
opportunity to do so. 
14.  WHAT WILL YOUR RESPONSIBILITIES BE, AS THE RESEARCHER? My responsibility, as a 
researcher, will be to collect the data as accurately as possible and to adhere to the 
guidelines of my research. I will keep all information about all participants confidential and 
will not falsify information about this research to my or any others benefit
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15. WHO IS ORGANISING AND FUNDING THIS RESEARCH STUDY? The study is being organised by 
me, under the guidance of my research supervisor at the Department of Chiropractic at the 
University of Johannesburg. This study has received funding from the supervisor linked bursary.  
16. WHO HAS REVIEWED AND APPROVED THIS STUDY? Before this study was allowed to start, it 
was reviewed in order to protect your interests. This review was done by the Department of 
Chiropractic, and then secondly by the Faculty of Health Sciences research Ethics Committee at 
the University of Johannesburg. In both cases, the study was approved. 
17. WHAT HAPPENS IF I GET INJURED DURING THE STUDY? This research is not covered by the 
institutional insurance.   
18. ARE THERE ANY CONFLICT OF INTERESTS PERTAINING TO THIS STUDY? There are no conflicts 
of interest held by anyone involved in this study.  
19. WHAT IF THERE IS A PROBLEM?   If you have any concerns or complaints about this research 
study, its procedures or risks and benefits, you should ask me. You should contact me at any 
time if you feel you have any concerns about being a part of this study. My contact details are: 
 
Alastair Lunn 083 291 7706 
alastairlunn@gmail.com  
You may also contact my research supervisor: 
Dr Malany Moodley  
mmoodley@uj.ac.za 
If you feel that any questions or complaints regarding your participation in this study have not been 
dealt with adequately, you may contact the Chairperson of the Faculty of Health Sciences Research 
Ethics Committee at the University of Johannesburg: 
Prof. Christopher Stein 
Tel: 011 559-6564 
Email: cstein@uj.ac.za  
FURTHER INFORMATION AND CONTACT DETAILS: Should you wish to have more specific information 
about this research project information, have any questions, concerns or complaints about this research 
study, its procedures, risks and benefits, you should communicate with me using any of the contact 
details given above. 
 
Researcher: 
Alastair Lunn  
93 
 
Appendix B: Research Consent Form 
 
 
 
 
 
 
 DEPARTMENT OF CHIROPRACTIC 
RESEARCH CONSENT FORM 
 
THE EFFECT OF SHOCKWAVE THERAPY OF THE GLUTEUS MAXIMUS AND 
TENSOR FASCIA LATA VERSUS THE ILIOTIBIAL BAND IN PATIENTS WITH 
ILIOTIBIAL BAND SYNDROME 
Please initial each box below: 
 
 
       I confirm that I have read and understand the information letter dated: 
_____________for the above study. I have had the opportunity to consider the 
information, ask questions and have had these answered satisfactorily. 
 
 
                    I understand that my participation is voluntary and that I am free to 
withdraw from this study at any time without giving any reason and without any 
consequences to me. 
 
 
      I agree to take part in the above study. 
 
 
 
 
 
_______________________       ___________________________________  ________________ 
Name of Participant        Signature of Participant    Date 
 
 
 
 
_______________________      ___________________________________ ________________ 
Name of Researcher     Signature of Researcher             Date 
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Appendix C: Informed Consent Form 
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Appendix D: Case History 
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Appendix E: Physical Examination 
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Appendix F: Hip Regional 
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Appendix G: Knee Regional 
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Appendix H: SOAP Note 
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You are invited to participate in a research study to compare the 
effect of shockwave therapy of gluteus maximus and tensor fascia 
lata muscles in ITB syndrome. 
 
If you are interested, come and visit me at the University of Johannesburg Chiropractic 
Day Clinic on Doornfontein Campus; Gate 7, Sherwell Road, Doornfontein.  
Please contact me Alastair Lunn 083 291 7706 
 
 
 
 
 
 
 
Appendix I: Advertisement 
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Appendix J: Permission letter to running/cycling clubs 
 
 
  
  
To whom it may concern 
 
My name is Alastair Lunn, I am currently completing my master’s degree in Chiropractic. 
I am a final year student in the process of completing my dissertation, which is a 
requirement of my degree. In order to do this, I will need to conduct a research study 
titled: the effect of shockwave therapy of the gluteus maximus and tensor fascia lata 
versus the iliotibial band in patients with iliotibial band syndrome. 
 
Due to the nature of ITB syndrome, many runners and cyclers suffer from this condition 
and I would appreciate been able to put up advertisements within your club, as this may 
help increase recruitment for my research. All information will be provided during the 
first consultation. Please feel free to contact me if you have any questions. 
 
Kind regards, 
Alastair Lunn 083 291 7706   
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Appendix K: Permission to Treat University of 
Johannesburg Doornfontein Campus Students 
 
 
 
  
  
Dear Dr Nonkwelo, 
My name is Alastair Lunn, I am currently completing my master’s degree in Chiropractic. 
I am a final year student in the process of completing my dissertation, which is a 
requirement of my degree. In order to do this, I will need to conduct a research study, 
which will involve the participation of students at the University of Johannesburg, 
Doornfontein campus.  
 
My research topic is: THE EFFECT OF SHOCKWAVE THERAPY OF THE GLUTEUS 
MAXIMUS AND TENSOR FASCIA LATA VERSUS THE ILIOTIBIAL BAND IN 
PATIENTS WITH ILIOTIBIAL BAND SYNDROME 
I am writing this email to request your permission to undertake research at the 
University of Johannesburg Doornfontein campus, and for students to partake in my 
research. 
Kind Regards,  
Alastair Lunn 
201372327 
Chiropractic student  
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Appendix L: Higher Degrees Committee Clearance Letter 
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Appendix M: Research Ethics Committee Clearance Letter 
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Appendix N: Trial Registration 
   
115 
 
Appendix O: Diagnostic Criteria for ITBS 
 
 
 
  
ITBS Diagnostic criteria (Noble, 1979; Khaund and Flynn, 2005) 
• Any participant, male or female, with pain over the lateral aspect of the knee 
just superior to the joint line of the knee. 
• A positive Noble’s compression test. 
• A positive Ober’s Test. 
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Appendix P: NPRS Readings 
0-10 pain scale. Please tick which box suits your pain currently 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
  
Reading 1 Reading 2 Reading 3 
0 (no pain)  0 (no pain)  0 (no pain)  
1   1   1   
2  2  2  
3  3  3  
4  4  4  
5 (moderate)  5 (moderate)  5 (moderate)  
6  6  6  
7  7  7  
8  8  8  
9  9  9  
10 (severe)  10 (severe)  10 (severe)   
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Appendix Q: Goniometer Readings 
 
 
 
  
  
Reading 
Flexion 
(⁰) 
Extension 
(⁰) 
Abduction 
(⁰) 
Adduction 
(⁰) 
Medial 
Rotation 
(⁰) 
Lateral 
Rotation 
(⁰) 
1             
Mean       
2             
Mean       
3             
Mean       
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Appendix R: Pressure Algometer Readings 
ITB: 
Reading 1 (kg/cm²)  Reading 2 (kg/cm²) Reading 3 (kg/cm²) 
      
Mean: Mean: Mean:  
 
TFL: 
Reading 1 (kg/cm²)  Reading 2 (kg/cm²) Reading 3 (kg/cm²) 
      
Mean: Mean: Mean:  
 
Gluteus Maximus: 
Reading 1 (kg/cm²)  Reading 2 (kg/cm²) Reading 3 (kg/cm²) 
      
Mean: Mean: Mean:  
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Appendix S: Turnitin Report 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
